10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

For the quarter ended September 30, 2014

Commission file number 1-10585

CHURCH & DWIGHT CO., INC.

(Exact name of registrant as specified in its charter)

Delaware	13-4996950
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

500 Charles Ewing Boulevard, Ewing, N.J. 08628

(Address of principal executive offices)

Registrant’s telephone number, including area code: (609) 806-1200

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Name of each exchange on which registered
Common Stock, $1 par value	New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding twelve months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	x	Accelerated filer	¨
Non-accelerated filer	¨	Smaller reporting company	¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No   x

As of October 29, 2014, there were 133,774,605 shares of Common Stock outstanding.

TABLE OF CONTENTS

PART I

Item		Page
1.	Financial Statements	3
2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	19
3.	Quantitative and Qualitative Disclosures about Market Risk	25
4.	Controls and Procedures	26

PART II

1.	Legal Proceedings	26
1A.	Risk Factors	27
2.	Unregistered Sales of Equity Securities and Use of Proceeds	27
6.	Exhibits	28

2

PART I – FINANCIAL INFORMATION

ITEM 1: FINANCIAL STATEMENTS

CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

(In millions, except per share data)

	Three Months Ended						Nine Months Ended
	September 30,			September 30,			September 30,			September 30,
	2014			2013			2014			2013
Net Sales	$	841.8		$	804.8		$	2,432.1		$	2,371.7
Cost of sales		474.3			439.6			1,368.8			1,305.4
Gross Profit		367.5			365.2			1,063.3			1,066.3
Marketing expenses		96.6			99.7			297.8			282.3
Selling, general and administrative expenses		93.7			97.7			288.1			306.4
Income from Operations		177.2			167.8			477.4			477.6
Equity in earnings (losses) of affiliates		3.4			1.9			7.9			1.4
Investment earnings		0.6			0.6			1.7			2.0
Other income (expense), net		(1.1	)		(0.1	)		(1.6	)		(1.4	)
Interest expense		(6.9	)		(7.0	)		(20.5	)		(21.0	)
Income before Income Taxes		173.2			163.2			464.9			458.6
Income taxes		57.3			55.3			157.6			156.4
Net Income	$	115.9		$	107.9		$	307.3		$	302.2
Weighted average shares outstanding - Basic		133.7			138.8			135.5			138.5
Weighted average shares outstanding - Diluted		136.0			141.3			137.9			141.1
Net income per share - Basic	$	0.87		$	0.78		$	2.27		$	2.18
Net income per share - Diluted	$	0.85		$	0.76		$	2.23		$	2.14
Cash dividends per share	$	0.31		$	0.28		$	0.93		$	0.84

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)

(In millions)

	Three Months Ended						Nine Months Ended
	September 30,			September 30,			September 30,			September 30,
	2014			2013			2014			2013
Net Income	$	115.9		$	107.9		$	307.3		$	302.2
Other comprehensive income, net of tax:
Foreign exchange translation adjustments		(19.3	)		7.8			(14.8	)		(7.0	)
Defined benefit plan adjustments		0.0			(0.1	)		0.7			0.2
Income (loss) from derivative agreements		0.9			(0.2	)		0.0			0.0
Other comprehensive income (loss)		(18.4	)		7.5			(14.1	)		(6.8	)
Comprehensive income	$	97.5		$	115.4		$	293.2		$	295.4

See Notes to Condensed Consolidated Financial Statements.

3

CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In millions, except share and per share data)

	September 30,			December 31,
	2014			2013
Assets
Current Assets
Cash and cash equivalents	$	370.2		$	496.9
Accounts receivable, less allowances of $1.5 and $0.8		321.3			330.2
Inventories		261.6			250.5
Deferred income taxes		19.5			16.6
Other current assets		20.2			21.6
Total Current Assets		992.8			1,115.8
Property, Plant and Equipment, Net		595.8			594.1
Equity Investment in Affiliates		24.8			24.5
Tradenames and Other Intangibles, Net		1,283.1			1,204.3
Goodwill		1,325.0			1,222.2
Other Assets		104.3			98.8
Total Assets	$	4,325.8		$	4,259.7
Liabilities and Stockholders' Equity
Current Liabilities
Short-term borrowings	$	404.1		$	153.8
Accounts payable and accrued expenses		502.3			495.1
Income taxes payable		12.0			2.3
Total Current Liabilities		918.4			651.2
Long-term Debt		649.6			649.5
Deferred Income Taxes		490.6			476.0
Deferred and Other Long-term Liabilities		155.8			157.5
Pension, Postretirement and Postemployment Benefits		24.0			25.5
Total Liabilities		2,238.4			1,959.7
Commitments and Contingencies
Stockholders' Equity
Preferred Stock, $1.00 par value, Authorized 2,500,000 shares; none issued		0.0			0.0
Common Stock, $1.00 par value, Authorized 300,000,000 shares; 146,427,550 shares issued		146.4			146.4
Additional paid-in capital		363.4			352.9
Retained earnings		2,349.8			2,168.5
Accumulated other comprehensive income (loss)		(13.9	)		0.2
Common stock in treasury, at cost: 12,806,896 shares in 2014 and 7,462,913 shares in 2013		(758.4	)		(368.1	)
Total Church & Dwight Co., Inc. Stockholders' Equity		2,087.3			2,299.9
Noncontrolling interest		0.1			0.1
Total Stockholders' Equity		2,087.4			2,300.0
Total Liabilities and Stockholders’ Equity	$	4,325.8		$	4,259.7

See Notes to Condensed Consolidated Financial Statements.

4

CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW

(Unaudited)

(In millions)

	Nine Months Ended
	September 30,			September 30,
	2014			2013
Cash Flow From Operating Activities
Net Income	$	307.3		$	302.2
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation expense		43.3			44.9
Amortization expense		24.4			23.0
Deferred income taxes		10.5			11.9
Equity in net (earnings) losses of affiliates		(7.9	)		(1.4	)
Distributions from unconsolidated affiliates		8.4			4.5
Non cash compensation expense		15.0			14.6
Asset impairment charge and other asset write-offs		5.6			1.1
Other		1.1			1.6
Change in assets and liabilities:
Accounts receivable		5.0			(24.4	)
Inventories		(10.0	)		(14.8	)
Other current assets		2.1			(3.5	)
Accounts payable and accrued expenses		(2.6	)		53.7
Income taxes payable		26.4			(24.5	)
Excess tax benefit on stock options exercised		(14.6	)		(9.8	)
Other operating assets and liabilities, net		(5.3	)		(2.5	)
Net Cash Provided By Operating Activities		408.7			376.6
Cash Flow From Investing Activities
Additions to property, plant and equipment		(36.2	)		(30.3	)
Acquisitions, net of cash acquired		(216.1	)		0.0
Investment interest in joint venture		(0.8	)		(5.7	)
Other		(0.5	)		(3.1	)
Net Cash Used In Investing Activities		(253.6	)		(39.1	)
Cash Flow From Financing Activities
Short-term debt borrowings (repayments)		250.4			(99.5	)
Proceeds from stock options exercised		24.5			16.2
Excess tax benefit on stock options exercised		14.6			9.8
Payment of cash dividends		(126.0	)		(116.3	)
Purchase of treasury stock		(435.0	)		(50.0	)
Lease incentive proceeds		0.0			10.9
Lease principal payments		(0.9	)		(0.8	)
Other		0.8			(0.3	)
Net Cash Used In Financing Activities		(271.6	)		(230.0	)
Effect of exchange rate changes on cash and cash equivalents		(10.2	)		(5.0	)
Net Change In Cash and Cash Equivalents		(126.7	)		102.5
Cash and Cash Equivalents at Beginning of Period		496.9			343.0
Cash and Cash Equivalents at End of Period	$	370.2		$	445.5

See Notes to Condensed Consolidated Financial Statements.

5

CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW-CONTINUED

(Unaudited)

(In millions)

	Nine Months Ended
	September 30,		September 30,
	2014		2013
Cash paid during the year for:
Interest (net of amounts capitalized)	$	14.2	$	14.9
Income taxes	$	122.2	$	171.1
Supplemental disclosure of non-cash investing activities:
Property, plant and equipment expenditures included in Accounts Payable	$	11.9	$	4.0

See Notes to Condensed Consolidated Financial Statements.

6

CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

For the Nine Months Ended September 30, 2014 and 2013

(Unaudited)

(In millions, except per share data)

	Number of Shares					Amounts
	Common Stock		Treasury Stock			Common Stock		Additional Paid-In Capital		Retained Earnings			Accumulated Other Comprehensive Income (Loss)			Treasury Stock			Total Church & Dwight Co., Inc. Stockholders' Equity			Noncontrolling Interest		Total Stockholders' Equity
December 31, 2012		146.4		(7.6	)	$	146.4	$	318.8	$	1,929.3		$	2.5		$	(336.1	)	$	2,060.9		$	0.2	$	2,061.1
Net income		0.0		0.0			0.0		0.0		302.2			0.0			0.0			302.2			0.0		302.2
Other comprehensive    income		0.0		0.0			0.0		0.0		0.0			(6.8	)		0.0			(6.8	)		0.0		(6.8	)
Cash dividends		0.0		0.0			0.0		0.0		(116.3	)		0.0			0.0			(116.3	)		0.0		(116.3	)
Stock purchases		0.0		(0.9	)		0.0		0.0		0.0			0.0			(50.0	)		(50.0	)		0.0		(50.0	)
Stock based compensation    expense and stock option plan    transactions, including related    income tax benefits of $10.0		0.0		0.8			0.0		36.1		0.0			0.0			4.4			40.5			0.0		40.5
September 30, 2013		146.4		(7.7	)	$	146.4	$	354.9	$	2,115.2		$	(4.3	)	$	(381.7	)	$	2,230.5		$	0.2	$	2,230.7
December 31, 2013		146.4		(7.5	)	$	146.4	$	352.9	$	2,168.5		$	0.2		$	(368.1	)	$	2,299.9		$	0.1	$	2,300.0
Net income		0.0		0.0			0.0		0.0		307.3			0.0			0.0			307.3			0.0		307.3
Other comprehensive    income		0.0		0.0			0.0		0.0		0.0			(14.1	)		0.0			(14.1	)		0.0		(14.1	)
Cash dividends		0.0		0.0			0.0		0.0		(126.0	)		0.0			0.0			(126.0	)		0.0		(126.0	)
Stock purchases		0.0		(6.4	)		0.0		0.0		0.0			0.0			(435.0	)		(435.0	)		0.0		(435.0	)
Stock based compensation    expense and stock option plan    transactions, including related    income tax benefits of $14.9		0.0		1.0			0.0		9.9		0.0			0.0			43.6			53.5			0.0		53.5
Other stock issuances		0.0		0.1			0.0		0.6		0.0			0.0			1.1			1.7			0.0		1.7
September 30, 2014		146.4		(12.8	)	$	146.4	$	363.4	$	2,349.8		$	(13.9	)	$	(758.4	)	$	2,087.3		$	0.1	$	2,087.4

See Notes to Condensed Consolidated Financial Statements.

7

CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(In millions, except per share data)

1. Basis of Presentation

The condensed consolidated balance sheets as of September 30, 2014 and December 31, 2013, the condensed consolidated statements of income and comprehensive income for the three and nine months ended September 30, 2014 and September 30, 2013, and the condensed consolidated statements of cash flow and stockholders’ equity for the nine months ended September 30, 2014 and September 30, 2013 have been prepared by Church & Dwight Co., Inc. (the “Company”). In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position at September 30, 2014 and results of operations and cash flow for all periods presented have been made.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles (“GAAP”) have been condensed or omitted. These condensed consolidated financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013 (the “Form 10-K”). The results of operations for the period ended September 30, 2014 are not necessarily indicative of the operating results for the full year.

The Company incurred research and development expenses in the third quarter of 2014 and 2013 of $14.8 and $16.3, respectively. The Company incurred research and development expenses in the first nine months of 2014 and 2013 of $42.3 and $45.0, respectively. These expenses are included in selling, general and administrative expenses.

2. New Accounting Pronouncements Adopted

In May 2014, the Financial Accounting Standards Board issued new guidance that clarifies the principles for recognizing revenue.  The new guidance provides that an entity should recognize revenue for the transfer of goods or services equal to the amount that it expects to receive for those goods or services.  The new guidance is effective for annual and interim periods beginning after December 15, 2016, and allows companies to apply the requirements retrospectively, either to all prior periods presented or through a cumulative adjustment in the year of adoption.  Early adoption is not allowed. The Company is currently evaluating the impact, if any, that the adoption of the new guidance will have on its consolidated financial position, results of operations or cash flows.

There have been no other accounting pronouncements issued but not yet adopted by the Company which are expected to have a material impact on the Company’s consolidated financial position, results of operations or cash flows.

3. Inventories

Inventories consist of the following:

	September 30,		December 31,
	2014		2013
Raw materials and supplies	$	68.4	$	70.2
Work in process		27.0		30.4
Finished goods		166.2		149.9
Total	$	261.6	$	250.5

8

4. Property, Plant and Equipment, Net (“PP&E”)

PP&E consist of the following:

	September 30,		December 31,
	2014		2013
Land	$	25.6	$	25.7
Buildings and improvements		281.1		280.4
Machinery and equipment		596.1		577.5
Software		84.1		83.0
Office equipment and other assets		61.4		57.7
Construction in progress		59.2		42.9
Gross Property, Plant and Equipment		1,107.5		1,067.2
Less accumulated depreciation and amortization		511.7		473.1
Net Property, Plant and Equipment	$	595.8	$	594.1

	Three Months Ended				Nine Months Ended
	September 30,		September 30,		September 30,		September 30,
	2014		2013		2014		2013
Depreciation and amortization on PP&E	$	13.9	$	14.1	$	43.3	$	44.9
Interest charges capitalized (in construction in    progress)	$	0.2	$	0.1	$	0.5	$	0.3

5. Earnings Per Share (“EPS”)

Basic EPS is calculated based on income available to holders of the Company’s common stock (“Common Stock”) and the weighted-average number of shares outstanding during the reported period. Diluted EPS includes additional dilution from potential Common Stock issuable pursuant to the exercise of outstanding stock options.

The following table sets forth a reconciliation of the weighted-average number of shares of Common Stock outstanding to the weighted-average number of shares outstanding on a diluted basis:

	Three Months Ended				Nine Months Ended
	September 30,		September 30,		September 30,		September 30,
	2014		2013		2014		2013
Weighted average common shares outstanding -    basic		133.7		138.8		135.5		138.5
Dilutive effect of stock options		2.3		2.5		2.4		2.6
Weighted average common shares outstanding -    diluted		136.0		141.3		137.9		141.1
Antidilutive stock options outstanding		1.2		1.6		1.2		1.6

On January 29, 2014, the Company’s board of directors (“the Board”) authorized a new share repurchase program, under which the Company may repurchase up to $500 of its common stock (“Common Stock”). This share repurchase program replaced the Company’s share repurchase program previously announced on November 5, 2012. In addition, the Board authorized a new evergreen share repurchase program, under which the Company may repurchase, from time to time, Common Stock to reduce or eliminate dilution associated with issuances of Common Stock under the Company’s incentive plans.

As part of the new share repurchase programs, in the first nine months of 2014 the Company entered into accelerated share repurchase (“ASR”) contracts with a commercial bank to purchase approximately 6.4 million shares of Common Stock for $435, of which $74 was purchased under the evergreen program and $361 was purchased under the share repurchase program.   As a result of these purchases, there remains $139 under the share repurchase program.

9

6. Stock Based Compensation Plans

The following table provides a summary of option activity during the nine months ended September 30, 2014:

						Weighted-
				Weighted-		Average
				Average		Remaining		Aggregate
				Exercise		Contractual		Intrinsic
	Options			Price		Term		Value
Outstanding at December 31, 2013		8.8		$	39.47
Granted		1.1			69.60
Exercised		(1.0	)		24.23
Cancelled		(0.1	)		55.32
Outstanding at September 30, 2014		8.8		$	44.90		6.3	$	222.1
Exercisable at September 30, 2014		4.5		$	29.79		4.3	$	182.5

The following table provides information regarding the intrinsic value of stock options exercised and stock compensation expense related to stock option awards:

	Three Months Ended				Nine Months Ended
	September 30,		September 30,		September 30,		September 30,
	2014		2013		2014		2013
Intrinsic Value of Stock Options Exercised	$	7.3	$	5.1	$	44.5	$	31.0
Stock Compensation Expense Related to Stock    Option Awards	$	1.7	$	1.9	$	13.5	$	13.3
Issued Stock Options		0.0		0.0		1.1		1.6
Weighted Average Fair Value of Stock Options    issued (per share)	$	12.76	$	11.31	$	12.84	$	10.90
Fair Value of Stock Options Issued	$	0.1	$	0.5	$	14.7	$	17.8

The following table provides a summary of the assumptions used in the valuation of issued stock options:

	Three Months Ended						Nine Months Ended
	September 30,			September 30,			September 30,			September 30,
	2014			2013			2014			2013
Risk-free interest rate		2.0	%		1.7	%		2.0	%		1.4	%
Expected life in Years		6.1			6.1			6.2			6.2
Expected volatility		20.4	%		21.2	%		20.4	%		21.2	%
Dividend Yield		1.8	%		1.8	%		1.8	%		1.8	%

The fair value of stock options is based upon the Black Scholes option pricing model. The Company determined the stock options’ lives based on historical exercise behavior and their expected volatility and dividend yield based on the historical changes in stock price and dividend payments. The risk free interest rate is based on the yield of an applicable term Treasury instrument.

7. Fair Value Measurements

Fair Value Hierarchy

Accounting guidance on fair value measurements and disclosures establishes a hierarchy that prioritizes the inputs used to measure fair value (generally, assumptions that market participants would use in pricing an asset or liability) based on the quality and reliability of the information provided by the inputs, as follows:

Level 1: Quoted market prices in active markets for identical assets or liabilities.

Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.

Level 3: Unobservable inputs that are not corroborated by market data.

The Company recognizes transfers between input levels as of the actual date of the event. There were no transfers between input levels during the nine months ended September 30, 2014.

10

Fair Values of Other Financial Instruments

The following table presents the carrying amounts and estimated fair values of the Company’s other financial instruments at September 30, 2014 and December 31, 2013:

		September 30, 2014				December 31, 2013
	Input	Carrying		Fair		Carrying		Fair
	Level	Amount		Value		Amount		Value
Financial Assets:
Cash equivalents	Level 2	$	240.3	$	240.3	$	318.5	$	318.5
Financial Liabilities:
Short-term borrowings	Level 2		404.1		404.1		153.8		153.8
2.875% Senior notes	Level 2		399.7		386.7		399.7		369.8
3.35% Senior notes	Level 2		249.9		258.0		249.8		258.2

The following methods and assumptions were used to estimate the fair value of each class of financial instruments reflected in the Consolidated Balance Sheets:

Cash Equivalents: Cash equivalents consist of highly liquid short-term investments and term bank deposits, which mature within three months. The estimated fair value of the Company’s cash equivalents approximates their carrying value.

Short-Term Borrowings: The carrying amounts of the Company’s unsecured lines of credit and commercial paper issuances approximates fair value because of their short maturities and variable interest rates.

Senior Notes: The Company determines the fair value of its senior notes based on their quoted market value or broker quotes, when possible. In the absence of observable market quotes, the notes are valued using non-binding market consensus prices that the Company seeks to corroborate with observable market data.

8. Derivative Instruments and Risk Management

The following tables summarize the fair value of the Company’s derivative instruments and the effect of such derivative instruments on the Company’s Consolidated Statements of Income and on Other Comprehensive Income (“OCI”):

		Notional		Fair Value at
		Amount		September 30,		December 31,
	Balance Sheet Location	September 30, 2014		2014		2013
Derivatives designated as hedging instruments
Asset Derivatives
Diesel fuel contracts	Other current assets	Not Applicable		$	0.0	$	0.3
Foreign exchange contracts	Other current assets	$	68.6		1.7		0.5
Total assets				$	1.7	$	0.8
Liability Derivatives
Diesel fuel contracts	Accounts payable and accrued expenses	5.7 gallons		$	1.1	$	0.0
Total liabilities				$	1.1	$	0.0
Derivatives not designated as hedging      instruments
Asset Derivatives
Equity derivatives	Other current assets	$	26.6	$	0.3	$	2.4
Total assets				$	0.3	$	2.4
Liability Derivatives
Foreign exchange contracts	Accounts payable and accrued expenses	$	1.6	$	0.1	$	0.0
Total liabilities				$	0.1	$	0.0

11

			Amount of Gain (Loss)
		Recognized in OCI
			from Derivatives
			for the Three Months Ended
	Other Comprehensive Income (Loss)		September 30,			September 30,
	Location		2014			2013
Derivatives designated as hedging instruments
Diesel fuel contracts (net of taxes)	Other comprehensive income (loss)		$	(0.8	)	$	0.2
Foreign exchange contracts (net of taxes)	Other comprehensive income (loss)			1.7			(0.4	)
Total gain (loss) recognized in OCI			$	0.9		$	(0.2	)
			Amount of Gain (Loss)
		Recognized in Income
			for the Three Months Ended
			September 30,			September 30,
	Income Statement Location		2014			2013
Derivatives not designated as hedging     instruments
Equity derivatives	Selling, general and administrative expenses		$	0.1		$	(0.7	)
Foreign exchange contracts	Selling, general and administrative expenses			0.0			(0.1	)
Total gain (loss) recognized in income			$	0.1		$	(0.8	)
			Amount of Gain (Loss)
		Recognized in OCI
			for the Nine Months Ended
	Other Comprehensive Income (Loss)		September 30,			September 30,
	Location		2014			2013
Derivatives designated as hedging instruments
Diesel fuel contracts (net of taxes)	Other comprehensive income (loss)		$	(1.0	)	$	0.0
Foreign exchange contracts (net of taxes)	Other comprehensive income (loss)			1.0			0.0
Total gain (loss) recognized in OCI			$	0.0		$	0.0
			Amount of Gain (Loss)
		Recognized in Income
			for the Nine Months Ended
			September 30,			September 30,
	Income Statement Location		2014			2013
Derivatives not designated as hedging     instruments
Equity derivatives	Selling, general and administrative expenses		$	1.4		$	2.6
Foreign exchange contracts	Selling, general and administrative expenses			0.0			(0.1	)
Total gain (loss) recognized in income			$	1.4		$	2.5

The notional amount of a derivative instrument is the nominal or face amount used to calculate payments made on that instrument. The fair values of the derivative instruments disclosed above were measured based on Level 2 inputs (observable market-based inputs or unobservable inputs that are corroborated by market data).

9. Acquisition

On September 19, 2014, the Company acquired certain feminine care brands, including REPHRESH and REPLENS, from Lil’ Drug Store Products, Inc., (“Lil’ Drug Store Brands Acquisition”) for cash consideration of $216.1. The Company paid for the acquisition with additional debt. The annual sales of the acquired brands are approximately $46.0. These feminine care brands will be managed within the Consumer Domestic and Consumer International segments.

The preliminary fair values of the net assets acquired are set forth as follows:

	Lil’ Drug Store
Inventory and other working capital	$	3.6
Property, plant and equipment		0.7
Tradenames and other intangibles		109.0
Goodwill		102.8
Purchase Price	$	216.1

12

The life of the amortizable intangible assets recognized from the Lil’ Drug Store Brands Acquisition ranges from 5 - 20 years. Pro forma results are not presented because the impact is not material to the Company’s consolidated financial results.

10. Goodwill and Other Intangibles, Net

The following table provides information related to the carrying value of all intangible assets, other than goodwill:

	September 30, 2014								December 31, 2013
	Gross							Amortization	Gross
	Carrying		Accumulated					Period	Carrying		Accumulated
	Amount		Amortization			Net		(Years)	Amount		Amortization			Net
Amortizable intangible assets:
Tradenames	$	254.8	$	(80.1	)	$	174.7	3-20	$	166.8	$	(73.9	)	$	92.9
Customer Relationships		347.3		(114.9	)		232.4	15-20		333.0		(100.4	)		232.6
Patents/Formulas		48.6		(37.9	)		10.7	4-20		43.5		(31.4	)		12.1
Non Compete Agreement		1.4		(1.4	)		0.0	5-10		1.4		(1.3	)		0.1
Total	$	652.1	$	(234.3	)	$	417.8		$	544.7	$	(207.0	)	$	337.7

Indefinite lived intangible assets - Carrying value

	September 30,		December 31,
	2014		2013
Tradenames	$	865.3	$	866.6

During the second quarter of 2014, the Company recorded an impairment charge of $5.0 for an intangible asset related to the Consumer Domestic segment. This charge is included in selling, general and administrative expenses in this segment and was the result of reduced sales and profitability related to the product line. The amount of the charge was determined from estimating that future cash flows would not be sufficient to recover the carrying amount of the asset.

Intangible amortization expense amounted to $7.5 and $7.0 for the third quarter of 2014 and 2013, respectively. Intangible amortization expense amounted to $22.7 and $21.5 for the first nine months of 2014 and 2013, respectively. The Company estimates that intangible amortization expense will be approximately $31.6 in 2014 and approximately $35.0 in each of the next five years.

The carrying amount of goodwill as of September 30, 2014 and December 31, 2013, respectively, is as follows:

	Consumer		Consumer		Specialty
	Domestic		International		Products		Total
Balance December 31, 2013	$	1,154.8	$	47.2	$	20.2	$	1,222.2
Lil' Drug Store Brands acquired goodwill		102.8		0.0		0.0		102.8
Balance September 30, 2014	$	1,257.6	$	47.2	$	20.2	$	1,325.0

The increase in goodwill and amortizable assets is due to the Lil’ Drug Store Brands Acquisition.

The result of the Company’s annual goodwill impairment test, performed in the beginning of the second quarter of 2014, determined that the estimated fair value substantially exceeded the carrying values of all reporting units.

13

11. Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses consist of the following:

	September 30,		December 31,
	2014		2013
Trade accounts payable	$	278.2	$	256.7
Accrued marketing and promotion costs		125.0		123.7
Accrued wages and related benefit costs		45.5		67.0
Other accrued current liabilities		53.6		47.7
Total	$	502.3	$	495.1

12. Short-Term Borrowings and Long-Term Debt

Short-term borrowings and long-term debt consist of the following:

	September 30,			December 31,
	2014			2013
Short-term borrowings
Commercial paper issuances	$	400.0		$	150.0
Various debt due to international banks		4.1			3.8
Total short-term borrowings	$	404.1		$	153.8
Long-term debt
2.875% Senior notes due October 1, 2022	$	400.0		$	400.0
Less: Discount		(0.3	)		(0.3	)
3.35% Senior notes due December 15, 2015		250.0			250.0
Less: Discount		(0.1	)		(0.2	)
Net long-term debt	$	649.6		$	649.5

13. Accumulated Other Comprehensive Income

The components of changes in accumulated other comprehensive income (“AOCI”) for the nine months ended September 30, 2014 and September 30, 2013 are as follows:

										Accumulated
	Foreign			Defined						Other
	Currency			Benefit			Derivative			Comprehensive
	Adjustments			Plans			Agreements			Income (Loss)
Balance December 31, 2012	$	22.8		$	(20.5	)	$	0.2		$	2.5
Other comprehensive income before reclassifications		(7.0	)		0.0			0.0			(7.0	)
Amounts reclassified to consolidated statement of    income (a) (b)		0.0			0.2			0.0			0.2
Other comprehensive income (loss)		(7.0	)		0.2			0.0			(6.8	)
Balance September 30, 2013	$	15.8		$	(20.3	)	$	0.2		$	(4.3	)
Balance December 31, 2013	$	12.7		$	(13.0	)	$	0.5		$	0.2
Other comprehensive income before reclassifications		(14.8	)		1.0			0.4			(13.4	)
Amounts reclassified to consolidated statement of    income (a) (b)		0.0			0.0			(0.6	)		(0.6	)
Tax benefit (expense)		0.0			(0.3	)		0.2			(0.1	)
Other comprehensive income (loss)		(14.8	)		0.7			0.0			(14.1	)
Balance September 30, 2014	$	(2.1	)	$	(12.3	)	$	0.5		$	(13.9	)

^(a) Amounts classified to cost of sales and selling, general and administrative expenses.

^(b) The Company reclassified a gain of $0.2 and $0.1 out of AOCI to the consolidated statement of income during the three months ended September 30, 2014 and 2013, respectively.

14

14. Benefit Plans

The following tables provide information regarding the net periodic benefit costs for the Company’s international pension plans and domestic and international nonpension postretirement plans:

	Pension Costs						Pension Costs
	Three Months ended						Nine Months Ended
	September 30,			September 30,			September 30,			September 30,
	2014			2013			2014			2013
Components of Net Periodic Benefit Cost:
Service cost	$	0.2		$	0.3		$	0.6		$	0.9
Interest cost		1.1			0.9			3.3			2.9
Expected return on plan assets		(1.6	)		(1.1	)		(4.6	)		(3.1	)
Amortization of prior service cost		0.6			0.3			0.8			0.7
Net periodic benefit cost (income)	$	0.3		$	0.4		$	0.1		$	1.4
	Nonpension						Nonpension
	Postretirement Costs						Postretirement Costs
	Three Months Ended						Nine Months Ended
	September 30,			September 30,			September 30,			September 30,
	2014			2013			2014			2013
Components of Net Periodic Benefit Cost:
Service cost	$	0.1		$	0.1		$	0.2		$	0.3
Interest cost		0.3			0.2			0.8			0.8
Amortization of prior service cost		(0.4	)		(0.4	)		(1.1	)		(0.6	)
Net periodic benefit cost (income)	$	0.0		$	(0.1	)	$	(0.1	)	$	0.5

The Company made cash contributions of approximately $2.4 to its pension plans during the first nine months of 2014. The Company estimates it will be required to make additional cash contributions to its pension plans of approximately $1.1 in the remainder of 2014 to offset 2014 benefit payments and administrative costs in excess of investment returns.

On May 7, 2014, the Company authorized the termination, effective December 31, 2014, of an international defined benefit pension plan under which approximately 280 participants, including 97 active employees, have accrued benefits.  The Company anticipates completing the termination of this plan by the end of the second quarter of 2015, once regulatory approvals are obtained. To effect the termination, the Company estimates, based on May 31, 2014 valuations, that the plan has sufficient assets to purchase annuities for retired participants and make certain deposits to the existing defined contribution plan of active employee participants. The Company estimates that it will incur a one-time non-cash expense of approximately $9 to $12 ($7 to $9 after tax) in 2015 when the plan settlement is completed. This expense is primarily attributable to pension settlement accounting rules which require accelerated recognition of actuarial losses that were to be amortized over the expected benefit lives of participants. The estimated expense is subject to change based on valuations at the actual date of settlement.

15. Commitments, Contingencies and Guarantees

Commitments

a. The Company has a partnership with a supplier of raw materials that mines and processes sodium-based mineral deposits. The Company purchases the majority of its sodium-based raw material requirements from the partnership. The partnership agreement for the partnership terminates upon two years’ written notice by either partner. Under the partnership agreement, the Company has an annual commitment to purchase 240,000 tons of sodium-based raw materials at the prevailing market price. With the exception of the Natronx Technologies LLC (“Natronx”) joint venture, in which the Company and the partner supplier are each one-third owners, the Company is not engaged in any other material transactions with the partnership or the partner supplier.

b. As of September 30, 2014, the Company had commitments through 2019 of approximately $231.3. These commitments include the purchase of raw materials, packaging supplies and services from its vendors at market prices to enable the Company to respond quickly to changes in customer orders or requirements, as well as costs associated with licensing and promotion agreements.

15

c. As of September 30, 2014, the Company had the following guarantees: (i) $4.7 in outstanding letters of credit drawn on several banks which guarantee payment for such things as insurance claims in the event of the Company’s insolvency, (ii) an insolvency protection guarantee of approximately $19.0 to one of its United Kingdom pension plans effective January 1, 2011, and (iii) $3.5 worth of assets subject to guarantees for its Brazil operations for value added tax assessments and labor related cases currently under appeal.

d. On November 8, 2011, the Company acquired a license for certain oral care technology for cash consideration of $4.3. In addition to this initial payment, the Company is required to make advance royalty payments of up to $5.5 upon the launch of a product utilizing the licensed technology, of which $4.3 had been made as of September 30, 2014. The Company is required to make an additional $7.0 license payment upon the approval of certain New Drug Applications by the U.S. Food and Drug Administration for products incorporating the acquired technology.

Environmental matter

e. In 2000, the Company acquired majority ownership in its Brazilian subsidiary, Quimica Geral Do Nordeste S.A. (“QGN”). The acquired operations included an inorganic salt manufacturing plant which began site operations in the late 1970’s. Located on the site were two closed landfills, two active landfills and a pond for the management of process waste streams. In 2009, QGN was advised by the environmental authority in the State of Bahia, the Institute of the Environment (“IMA”), that the plant was discharging contaminants into an adjacent creek. After learning of the discharge, QGN took immediate action to cease the discharge and retained two nationally recognized environmental firms to prepare a site investigation / remedial action (“SI/RA”) report. The SI/RA report was submitted by QGN to IMA in April 2010. The report concluded that the likely sources of the discharge were the failure of the pond and closed landfills. QGN ceased site operations in August 2010. In November 2010, IMA responded to QGN’s recommendation for an additional study by issuing a notification requiring a broad range of remediation measures (the “Remediation Notification”), which included the shutdown and removal of two on-site landfills. In addition, despite repeated discussions with IMA at QGN’s request to consider QGN’s proposed remediation alternatives, in December 2010, IMA imposed a fine of five million Brazilian Real (approximately U.S. $2.0 at current exchange rates) for the discharge of contaminants above allowable limits. The description of the fine included a reference to aggravating factors that may indicate that local “management’s intent” was considered in determining the severity of the fine, which could result in criminal liability for members of local management. In January 2011, QGN filed with IMA an administrative defense to the fine, suspending any enforcement activities pending its defense. IMA has not yet formally responded to QGN’s administrative defense.

With respect to the Remediation Notification, QGN engaged in discussions with IMA during which QGN asserted that a number of the remediation measures, including the removal of the landfills, and the timeframes for implementation were not appropriate and requested that the Remediation Notification be withdrawn. In response, in February 2011, IMA issued a revised Remediation Notification (the “Revised Remediation Notification”) providing for further site analysis by QGN, including further study of the integrity of the landfills. The Revised Remediation Notification did not include a requirement to remove the landfills; however, it did not foreclose the possibility of such a requirement. QGN has responded to the Revised Remediation Notification providing further information regarding the remediation measures, and is in discussions with the Institute of Environment and Waste Management (“INEMA”), successor to IMA, to seek agreement on an appropriate remediation plan. In mid-2011, QGN, consistent with the Revised Remediation Notice, began an additional site investigation and capped the two active landfills. In 2012, QGN drained the waste pond. During the third quarter of 2013, INEMA approved the first step in QGN’s proposed remediation plans, the installation of a trench drain to capture and treat groundwater at the site. Construction of the trench drain began during the first quarter of 2014 and is expected to be completed during the fourth quarter 2014. In June 2014, QGN formally submitted to INEMA a technical report, including a remediation plan for the site and a proposed agreement regarding the fine and QGN’s ongoing obligations at the site. In July 2014, an initial meeting was held with INEMA to review and discuss the report and the proposed agreement. After the meeting QGN has provided additional information regarding the remediation plan in response to requests by INEMA.

As a result of the foregoing events, the Company accrued approximately $3.0 in 2009 and $4.8 in 2010 for remediation, fines and related costs. Since 2009, the costs of remediation activities and foreign exchange rate changes have reduced the accrual by approximately $4.4 to a current amount of $3.4. As a result of INEMA’s approval of the first step in QGN’s remediation plans, the Company does not believe that QGN will be required to remove the landfills. However, it remains reasonably possible that INEMA will require such removal, and the Company could be unsuccessful in appealing such decision. The Company estimates the cost of such landfill removal to be in the range of $30 to $50.

Legal and tax proceedings

f. The Company has recorded liabilities for uncertain income tax positions that, although supportable, may be challenged by tax authorities. The Company’s liabilities for uncertain income tax positions are $4.4 as of September 30, 2014.  The Company does not expect a material change in the liabilities for uncertain income tax positions within the next twelve months.

16

g. In addition, in conjunction with the Company’s acquisition and divestiture activities, the Company entered into select guarantees and indemnifications of performance with respect to the fulfillment of the Company’s commitments under applicable purchase and sale agreements. The arrangements generally indemnify the buyer or seller for damages associated with breach of contract, inaccuracies in representations and warranties surviving the closing date and satisfaction of liabilities and commitments retained under the applicable contract. Representations and warranties that survive the closing date generally survive for periods up to five years or the expiration of the applicable statutes of limitations. Potential losses under the indemnifications are generally limited to a portion of the original transaction price, or to other lesser specific dollar amounts for select provisions. With respect to sale transactions, the Company also routinely enters into non-competition agreements for varying periods of time. Guarantees and indemnifications with respect to acquisition and divestiture activities, if triggered, could have a materially adverse impact on the Company’s financial condition and results of operations.

h. The Company, in the ordinary course of its business, is the subject of, or party to, various pending or threatened legal and regulatory proceedings. Such proceedings are subject to many uncertainties, and the outcome of certain individual litigated matters and other proceedings, whether actual or threatened, may not be reasonably predictable and any related damages or liability may not be estimable. Certain legal and regulatory proceedings, including those described above, could result in an adverse outcome for the Company, and any such adverse outcome could have a material adverse effect on the Company’s business, financial condition, results of operations and cash flows.

16. Related Party Transactions

The following summarizes the balances and transactions between the Company and each of (i) Armand Products Company (“Armand”) and The ArmaKleen Company (“ArmaKleen”), in which the Company holds a 50% ownership interest, and (ii) Natronx, in which the Company holds a one-third ownership interest:

	Armand				ArmaKleen				Natronx
	Nine Months Ended				Nine Months Ended				Nine Months Ended
	September 30,		September 30,		September 30,		September 30,		September 30,		September 30,
	2014		2013		2014		2013		2014		2013
Purchases by Company	$	20.3	$	17.1	$	0.0	$	0.0	$	0.0	$	0.0
Sales by Company	$	0.0	$	0.0	$	0.9	$	1.0	$	1.5	$	1.3
Outstanding Accounts    Receivable	$	0.2	$	0.5	$	0.6	$	0.4	$	0.1	$	0.1
Outstanding Accounts Payable	$	2.8	$	2.0	$	0.0	$	0.0	$	0.0	$	0.0
Administration & Management    Oversight Services (1)	$	1.7	$	1.4	$	1.5	$	1.6	$	0.6	$	0.9

⁽¹⁾ Billed by Company and recorded as a reduction of selling, general and administrative expenses.

The Company recorded a $3.2 impairment charge associated with one of its affiliates in the second quarter of 2013. The charge, recorded in Equity in Earnings (Losses) of Affiliates, is a result of the Company’s assessment of the financial impact from the delay in anticipated discounted cash flows from the affiliate.

17. Segments

Segment Information

The Company operates three reportable segments: Consumer Domestic, Consumer International and Specialty Products Division (“SPD”). These segments are determined based on differences in the nature of products and organizational and ownership structures. The Company also has a Corporate segment.

Segment revenues are derived from the sale of the following products:

Segment	Products
Consumer Domestic	Household and personal care products
Consumer International	Primarily personal care products
SPD	Specialty chemical products

The Corporate segment income consists of equity in earnings (losses) of affiliates. As of September 30, 2014, the Company held 50% ownership interests in each of Armand and ArmaKleen, respectively, and a one-third ownership interest in Natronx. The

17

Company’s equity in earnings (losses) of Armand, ArmaKleen and Natronx for the three and nine months ended September 30, 2014 and September 30, 2013 are included in the Corporate segment.

Some of the subsidiaries that are included in the Consumer International segment manufacture and sell personal care products to the Consumer Domestic segment. These sales are eliminated from the Consumer International segment results set forth in the table below.

Segment Net Sales and Income before Income Taxes for the three and nine months ended September 30, 2014 and September 30, 2013 are as follows:

	Consumer		Consumer
	Domestic		International		SPD		Corporate(3)		Total
Net Sales(1)
Third Quarter 2014	$	627.2	$	136.2	$	78.4	$	0.0	$	841.8
Third Quarter 2013		605.3		134.5		65.0		0.0		804.8
First Nine Months of 2014	$	1,819.4	$	396.6	$	216.1	$	0.0	$	2,432.1
First Nine Months of 2013		1,790.8		396.5		184.4		0.0		2,371.7
Income before Income Taxes(2)
Third Quarter 2014	$	141.4	$	15.0	$	13.4	$	3.4	$	173.2
Third Quarter 2013		136.0		15.5		9.8		1.9		163.2
First Nine Months of 2014	$	376.0	$	47.5	$	33.5	$	7.9	$	464.9
First Nine Months of 2013		383.2		53.0		21.0		1.4		458.6

⁽¹⁾ Intersegment sales from Consumer International to Consumer Domestic were $0.3 and $0.7 for the quarters ended September 30, 2014 and September 30, 2013, respectively, and were $0.8 and $1.9 for the nine months ended September 30, 2014 and September 30, 2013, respectively.

⁽²⁾ In determining Income before Income Taxes, interest expense, investment earnings and other income (expense) were allocated among segments based upon each segment’s relative operating profit.

⁽³⁾ Corporate consists of equity in earnings (losses) of affiliates from Armand, ArmaKleen and Natronx.

Product line revenues from external customers are as follows:

	Three Months Ended				Nine Months Ended
	September 30,		September 30,		September 30,		September 30,
	2014		2013		2014		2013
Household Products	$	379.5	$	369.0	$	1,087.2	$	1,081.8
Personal Care Products		247.7		236.3		732.2		709.0
Total Consumer Domestic		627.2		605.3		1,819.4		1,790.8
Total Consumer International		136.2		134.5		396.6		396.5
Total SPD		78.4		65.0		216.1		184.4
Total Consolidated Net Sales	$	841.8	$	804.8	$	2,432.1		2,371.7

Household Products include laundry, deodorizing, and cleaning products. Personal Care Products include condoms, pregnancy kits, oral care products, skin care products and gummy dietary supplements.

18

CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES

(In millions, except per share data)

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS OF OPERATIONS

Results of Operations

Consolidated results

Net Sales

Net sales for the quarter ended September 30, 2014 were $841.8, an increase of $37.0 or 4.6% over the third quarter of 2013. Net sales for the nine months ended September 30, 2014 were $2,432.1, an increase of $60.4 or 2.5% over the comparable nine month period of 2013.The components of the net sales increase are as follows:

	Three Months Ended			Nine Months Ended
	September 30,			September 30,
Net Sales - Consolidated	2014			2014
Product volumes sold		5.2	%		4.4	%
Pricing/Product mix		(0.5	%)		(1.4	%)
Foreign exchange rate fluctuations		0.0	%		(0.3	%)
Acquired product lines(1)		0.1	%		0.0	%
Divested product lines		(0.2	%)		(0.2	%)
Net Sales increase		4.6	%		2.5	%

⁽¹⁾ On September 19, 2014, the Company acquired certain feminine care brands from Lil’ Drug Store Products Inc. (“Lil’ Drug Store Brands Acquisition”).Net sales of the brands acquired in the Lil’ Drug Store Brands Acquisition are included in the Company’s results since the date of acquisition.

For the three months ended September 30, 2014, the volume change primarily reflects increased product sales in all segments. Unfavorable price/mix in Consumer Domestic and Consumer International, primarily due to higher trade spending, was partially offset by favorable price/mix in SPD. For the nine months ended September 30, 2014, unfavorable price/mix in Consumer Domestic, primarily due to new product introductory costs, and Consumer International was partially offset by favorable price/mix in SPD.

Gross Profit

The Company’s gross profit was $367.5 for the quarter ended September 30, 2014, a $2.3 increase as compared to the same period in 2013 due primarily to higher sales volume partially offset by higher commodity costs and trade promotion spending.The Company’s gross profit was $1,063.3 for the nine month period ended September 30, 2014, a $3.0 decrease as compared to the same period in 2013 due to the effect of the costs associated with new product launches and higher commodity costs, partially offset by higher sales volumes. Gross margin decreased 170 basis points to 43.7% in the third quarter of 2014 as compared to 45.4% in same period in 2013, and gross margin decreased 130 basis points to 43.7% in the first nine months of 2014 as compared to 45.0% in the same period of 2013. Gross margin was lower due to higher trade promotion, coupon, slotting and commodity costs, partially offset by the positive impact of productivity improvement programs.

Operating Costs

Marketing expenses for the third quarter of 2014 were $96.6, a decrease of $3.1 as compared to the same period in 2013.  In the third quarter of 2014, higher marketing costs associated with introductory products were offset by lower costs on other brands.Marketing expenses as a percentage of net sales were 11.5% in the third quarter of 2014 as compared to 12.4% in the same period in 2013. Marketing expenses for the first nine months of 2014 were $297.8, an increase of $15.5 as compared to the same period in 2013 due primarily to expenses in support of new product launches and increased expenses in certain other power brands. Marketing expenses as a percentage of net sales were 12.2% in the first nine months of 2014 as compared to 11.9% in the same period in 2013.

Selling, general and administrative (“SG&A”) expenses were $93.7 in the third quarter of 2014, a decrease of $4.0 as compared to the same period in 2013 due primarily to lower compensation and benefit costs and research and development costs recorded in the current period, and cease use charges recorded in 2013 associated with the Company’s Princeton leased buildings, partially offset by higher litigation costs. SG&A for the first nine months of 2014 were $288.1, a decrease of $18.3 as compared to the same period in

19

2013 due primarily to lower compensation costs and research and development costs partially offset by a $5.0 intangible asset impairment charge.  Additionally, in 2013 the Company incurred costs related to the integration of the gummy dietary supplements business and recorded cease use charges associated with the Company’s Princeton leased buildings. SG&A as a percentage of net sales was 11.1% in the third quarter of 2014 as compared to approximately 12.2% in the same period in 2013. SG&A as a percentage of net sales was 11.9% in the first nine months of 2014 as compared to approximately 13.0% in the same period in 2013.

Other Income and Expenses

Equity in earnings of affiliates increased by $1.5 and $6.5 for the three and nine month periods ended September 30, 2014, respectively, as compared to the same periods in 2013.The increase in earnings was due primarily to profit improvement from Armand and lower expenses at Natronx.Also, in the second quarter of 2013, the Company recorded an impairment charge associated with one of its affiliates.

Other expense increased $1.0 million in the current quarter due to the effect of changes in foreign currencies.

Interest expense in the three and nine month periods ended September 30, 2014 decreased $0.1 and $0.5, respectively, compared to the same periods in 2013.

Taxation

The effective tax rate in the three and nine month periods ended September 30, 2014 was 33.1% and 33.9% respectively, compared to 33.9% and 34.1% respectively, in the same periods in 2013.The reduction in the current quarter rate is primarily due to the impact of favorable discrete adjustments related to uncertain income tax positions.  The 2014 annual effective tax rate is projected to be approximately 34%.

Segment results

The Company operates three reportable segments: Consumer Domestic, Consumer International and SPD.These segments are determined based on differences in the nature of products and organizational and ownership structures. The Company also has a Corporate segment.

Segment	Products
Consumer Domestic	Household and personal care products
Consumer International	Primarily personal care products
SPD	Specialty chemical products

The Corporate segment income consists of equity in earnings (losses) of affiliates. As of September 30, 2014, the Company held 50% ownership interests in each of Armand and ArmaKleen, respectively, and a one-third ownership interest in Natronx. The Company’s equity in earnings (losses) of Armand, ArmaKleen and Natronx for the three and nine month periods ended September 30, 2014 and September 30, 2013 are included in the Corporate segment.

Some of the subsidiaries that are included in the Consumer International segment manufacture and sell personal care products to the Consumer Domestic segment.These sales are eliminated from the Consumer International segment results set forth below.

20

Segment net sales and income before income taxes for the three and nine month periods ended September 30, 2014 and September 30, 2013 are as follows:

	Consumer		Consumer
	Domestic		International		SPD		Corporate(3)		Total
Net Sales(1)
Third Quarter 2014	$	627.2	$	136.2	$	78.4	$	0.0	$	841.8
Third Quarter 2013		605.3		134.5		65.0		0.0		804.8
First Nine Months of 2014	$	1,819.4	$	396.6	$	216.1	$	0.0	$	2,432.1
First Nine Months of 2013		1,790.8		396.5		184.4		0.0		2,371.7
Income before Income Taxes(2)
Third Quarter 2014	$	141.4	$	15.0	$	13.4	$	3.4	$	173.2
Third Quarter 2013		136.0		15.5		9.8		1.9		163.2
First Nine Months of 2014	$	376.0	$	47.5	$	33.5	$	7.9	$	464.9
First Nine Months of 2013		383.2		53.0		21.0		1.4		458.6

⁽¹⁾ Intersegment sales from Consumer International to Consumer Domestic, which are not reflected in the table, were $0.3 and $0.7 for the quarter ended September 30, 2014 and September 30, 2013, respectively, and $0.8 and $1.9 for the nine months ended September 30, 2014 and September 30, 2013, respectively.

⁽²⁾ In determining Income before Income Taxes, interest expense, investment earnings, and other income (expense) were allocated among the segments based upon each segment’s relative Income from Operations.

⁽³⁾ Corporate segment consists of equity in earnings (losses) of affiliates from Armand, ArmaKleen and Natronx.

Product line revenues from external customers are as follows:

	Three Months Ended				Nine Months Ended
	September 30,		September 30,		September 30,		September 30,
	2014		2013		2014		2013
Household Products	$	379.5	$	369.0	$	1,087.2	$	1,081.8
Personal Care Products		247.7		236.3		732.2		709.0
Total Consumer Domestic		627.2		605.3		1,819.4		1,790.8
Total Consumer International		136.2		134.5		396.6		396.5
Total SPD		78.4		65.0		216.1		184.4
Total Consolidated Net Sales	$	841.8	$	804.8	$	2,432.1		2,371.7

Household Products include laundry, deodorizing, and cleaning products. Personal Care Products include condoms, pregnancy kits, oral care products, skin care products and gummy dietary supplements.

Consumer Domestic

Consumer Domestic net sales in the third quarter of 2014 were $627.2, an increase of $21.9 or 3.6% as compared to the same period in 2013. Consumer Domestic net sales for the nine months ended September 30, 2014 were $1,819.4, an increase of $28.6 or 1.6% as compared to the same period in 2013. The components of the net sales change are the following:

	Three Months Ended			Nine Months Ended
	September 30,			September 30,
Net Sales - Consumer Domestic	2014			2014
Product volumes sold		4.3	%		3.4	%
Pricing/Product mix		(0.8	%)		(1.8	%)
Acquired product lines(1)		0.1	%		0.0	%
Net Sales increase		3.6	%		1.6	%

⁽¹⁾ Includes net sales of the brands acquired in the Lil’ Drug Store Brands Acquisition since the date of acquisition.

21

In the third quarter of 2014, the increase in net sales reflects higher sales for the recently introduced ARM & HAMMER CLUMP & SEAL cat litter and OXICLEAN liquid laundry detergent, and higher sales for TROJAN condoms and VITAFUSION gummy dietary supplements, partially offset by declining sales in XTRA laundry detergent, L’IL CRITTER gummy dietary supplements and ARM & HAMMER unit dose and powder laundry detergents. The increase in net sales for the nine months ended September 30, 2014 includes the new product launches of ARM & HAMMER CLUMP & SEAL cat litter and OXICLEAN liquid laundry detergent, and higher sales of OXICLEAN laundry additive products, TROJAN products, VITAFUSION gummy dietary supplements and NAIR depilatories, partially offset by declining sales in XTRA laundry detergent, L’IL CRITTER gummy dietary supplements and ARM & HAMMER laundry detergent.

Since the 2012 introduction in the U.S. of unit dose laundry detergent by various manufacturers, including the Company, there has been significant product and price competition in the laundry detergent category, contributing to an overall category decline. During 2013, the category declined by 3.2%. In 2014, the Procter & Gamble Company, one of the Company’s major competitors and the market leader in laundry detergent, has taken several competitive actions, including launching a lower-priced laundry detergent that competes directly with the Company’s core value laundry detergents. This, together with expected ongoing weak consumer spending and aggressive price competition by other laundry competitors, has negatively impacted the Company’s laundry detergent business. Over the last twelve months, the category declined 3.0%. The Company is vigorously combating these pressures through, among other things, significant new product introductions and increased marketing spending. There is no assurance that the category will not decline further and that the Company will be able to offset any such category decline.

Consumer Domestic income before income taxes for the third quarter of 2014 was $141.4, a $5.4 increase as compared to the third quarter of 2013. The increase is due primarily to the impact of higher sales volumes, manufacturing costs savings resulting from productivity improvement projects and lower marketing and SG&A costs, partially offset by higher trade promotion spending and higher commodity costs. For the nine month period ended September 30, 2014, income before income taxes was $376.0, a $7.2 decrease as compared to the first nine months of 2013 due to introductory trade promotion, coupon and marketing costs in support of new product launches, higher commodity costs and a $5.0 intangible asset impairment charge, partially offset by the impact of higher sales volumes, manufacturing costs savings resulting from productivity improvement projects and lower marketing and SG&A costs.

Consumer International

Consumer International net sales were $136.2 in the third quarter of 2014, an increase of $1.7 or 1.3% as compared to the same period in 2013. Consumer International net sales in the first nine months of 2014 were $396.6, an increase of $0.1 as compared to the same period in 2013. The components of the net sales change are the following:

	Three Months Ended			Nine Months Ended
	September 30,			September 30,
Net Sales - Consumer International	2014			2014
Product volumes sold		3.1	%		2.4	%
Pricing/Product mix		(1.4	%)		(0.5	%)
Foreign exchange rate fluctuations		0.1	%		(1.3	%)
Divested product lines		(0.5	%)		(0.6	%)
Net Sales increase (decrease )		1.3	%		0.0	%

Higher sales in the third quarter of 2014 occurred primarily in Mexico, the United Kingdom and Brazil, offset by lower U.S. exports and lower sales in Canada.Sales were flat in the first nine months of 2014 due to higher sales in the United Kingdom, Mexico, Brazil and France, offset by lower U.S. exports and lower sales in Canada.

Consumer International income before income taxes was $15.0 in the third quarter of 2014, a decrease of $0.5 compared to the same period in 2013 due primarily to the effect of foreign exchange rate changes and higher marketing expenses. For the first nine months of 2014, income before income taxes was $47.5, a $5.5 decrease as compared to the same period of 2013, due primarily to the same factors as those applicable to the third quarter of 2014.

22

Specialty Products

SPD net sales were $78.4 for the third quarter of 2014, an increase of $13.4 or 20.6% as compared to the same period in 2013. SPD net sales were $216.1 for the first nine months of 2014, an increase of $31.7 or 17.2% as compared to the same period of 2013. The components of the net sales change are the following:

	Three Months Ended			Nine Months Ended
	September 30,			September 30,
Net Sales - SPD	2014			2014
Product volumes sold		18.2	%		18.2	%
Pricing/Product mix		3.9	%		1.1	%
Foreign exchange rate fluctuations		0.0	%		(1.0	)%
Divested product lines		(1.5	)%		(1.1	)%
Net Sales increase		20.6	%		17.2	%

The net sales increase in the third quarter of 2014 reflects higher sales volume of animal nutrition products and performance products. The animal nutrition business’s strong performance is primarily related to the strength of the U.S. dairy industry, which has experienced high milk prices and low input commodity costs, prompting dairy producers to feed more animal nutrition products and produce higher volumes of milk per cow. The increase in net sales for the nine months ended September 30, 2014 is due primarily to the same factors as those applicable to the third quarter of 2014.

SPD income before income taxes was $13.4 in the third quarter of 2014, an increase of $3.6 as compared to the same period in 2013, and was $33.5 for the first nine months of 2014, an increase of $12.5 as compared to the same period in 2013. The increase in income before income taxes in the three and nine month periods of 2014 is due primarily to higher sales volume and sales prices and lower SG&A costs. Manufacturing costs were higher in the three months ended September 30, 2014 as compared to the same period in 2013, but were slightly lower than the prior year for the nine months ended September 30, 2014.

Corporate

The Corporate segment reflects the equity in earnings (losses) of affiliates from Armand, ArmaKleen and Natronx. The Corporate segment income before income taxes was $3.4 in the third quarter of 2014, an increase of $1.5 as compared to the same period in 2013. The Corporate segment income before income taxes was $7.9 for the first nine months of 2014, an increase of $6.5 as compared to the same period in 2013. In the second quarter of 2013 the Company recorded an impairment charge associated with one of its affiliates.

Liquidity and capital resources

As of September 30, 2014, the Company had $370.2 in cash and cash equivalents, approximately $100 available through the revolving facility under its principal credit agreement (“Credit Agreement”) and its commercial paper program, and a commitment increase feature under the Credit Agreement that enables the Company to borrow up to an additional $500, subject to lending commitments of the participating lenders and certain conditions as described in the Credit Agreement. To preserve its liquidity, the Company invests its cash primarily in prime money market funds and short term bank deposits.

As of September 30, 2014, the amount of cash and cash equivalents included in the Company’s assets, that was held by foreign subsidiaries was $242.8. If these funds are needed for operations in the U.S., the Company will be required to accrue and pay taxes in the U.S. to repatriate these funds.  However, the Company’s intent is to permanently reinvest these funds outside the U.S., and the Company does not currently expect to repatriate them to fund operations in the U.S.

The current economic environment presents risks that could have adverse consequences for the Company’s liquidity. (See “Unfavorable economic conditions could adversely affect demand for the Company’s products” under “Risk Factors” in Item 1A of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2013 (the “Form 10-K”).) The Company does not anticipate that current economic conditions will adversely affect its ability to comply with the financial covenants in the Credit Agreement because the Company currently is, and anticipates that it will continue to be, in compliance with the minimum interest coverage ratio requirement and the maximum leverage ratio requirement under the Credit Agreement. These financial ratios are discussed in more detail in this section under “Certain Financial Covenants.”

On January 29, 2014, the Company’s board of directors (“the Board”) authorized a new share repurchase program, under which the Company may repurchase up to $500 of its common stock (“Common Stock”). This share repurchase program replaced the

23

Company’s share repurchase program previously announced on November 5, 2012. In addition, the Board authorized a new evergreen share repurchase program, under which the Company may repurchase, from time to time, Common Stock to reduce or eliminate dilution associated with issuances of Common Stock under the Company’s incentive plans.

As part of the new share repurchase programs, in the first nine months of 2014 the Company entered into accelerated share repurchase (“ASR”) contracts with a commercial bank to purchase approximately 6.4 million shares of Common Stock for $435, of which $74 was purchased under the evergreen program and $361 was purchased under the share repurchase program.  As a result of these purchases, there remains $139 under the share repurchase program.

The Company anticipates that its available cash and cash from operations will be sufficient to meet its capital expenditure program costs, which are expected to be approximately $70.0 in 2014, fund its share repurchase program to the extent implemented by management and pay dividends at the latest approved rate. Cash, together with the Company’s current borrowing capacity, may be used for acquisitions that would complement the Company’s existing product lines or geographic markets. The Company does not have any mandatory fixed rate debt principal payments in 2014.

Net Debt

The Company had outstanding total debt of $1,053.7 and cash of $370.2, resulting in net debt of $683.5 at September 30, 2014. This compares to total debt of $803.3 and cash of $496.9, resulting in net debt of $306.4 at December 31, 2013. Net debt is defined as the sum of short-term debt and long-term debt, minus cash and cash equivalents.

Cash Flow Analysis

	Nine Months Ended
	September 30,			September 30,
	2014			2013
Net cash provided by operating activities	$	408.7		$	376.6
Net cash used in investing activities	$	(253.6	)	$	(39.1	)
Net cash used in financing activities	$	(271.6	)	$	(230.0	)

Net Cash Provided by Operating Activities – The Company’s net cash provided by operating activities in the first nine months of 2014 increased by $32.1 to $408.7 as compared to the same period in 2013 due to higher net income. Net cash provided by operating activities in 2013 was negatively affected by the deferred payment of the fourth quarter 2012 federal tax obligation of $36.0 as allowed by the IRS due to the impact of Hurricane Sandy.

Net Cash Used in Investing Activities – Net cash used in investing activities during the first nine months of 2014 was $253.6, principally reflecting the $216.1 paid for the Lil’ Drug Store Brands Acquisition, and $36.2 for property, plant and equipment expenditures.

Net Cash Used in Financing Activities – Net cash used in financing activities during the first nine months of 2014 was $271.6, primarily reflecting $435.0 of repurchases of Common Stock, $126.0 of cash dividends offset by an increase in  short-term debt of $250.4 to fund the Lil’ Drug Store Brands Acquisition and $39.1 of proceeds and tax benefits from stock option exercises.

Certain Financial Covenants

“Consolidated EBITDA” (referred to below as “Adjusted EBITDA” and defined in the Credit Agreement) is a component of the financial covenants contained in the Credit Agreement. Such financial covenants include a leverage ratio (total debt to Adjusted EBITDA) and an interest coverage ratio (Adjusted EBITDA to total interest expense), which, if not met, could result in an event of default and trigger the early termination of the Credit Agreement. Adjusted EBITDA may not be comparable to similarly titled measures used by other entities and should not be considered as an alternative to cash flows from operating activities determined in accordance with accounting principles generally accepted in the U.S. The Company’s leverage ratio for the twelve months ended September 30, 2014 was 1.5, which is below the maximum of 3.5 permitted under the Credit Agreement, and the interest coverage ratio for the twelve months ended September 30, 2014 was 30.0, which is above the minimum of 3.0 required under the Credit Agreement.

24

New Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board issued new guidance that clarifies the principles for recognizing revenue.  The new guidance provides that an entity should recognize revenue for the transfer of goods or services equal to the amount that it expects to receive for those goods or services.  The new guidance is effective for annual and interim periods beginning after December 15, 2016, and allows companies to apply the requirements retrospectively, either to all prior periods presented or through a cumulative adjustment in the year of adoption.  Early adoption is not allowed. The Company is currently evaluating the impact, if any, that the adoption of the new guidance will have on its consolidated financial position, results of operations or cash flows.

There have been no other accounting pronouncements issued but not yet adopted by the Company which are expected to have a material impact on the Company’s consolidated financial position, results of operations or cash flows.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK

Market risk

Interest Rate Risk

The Company had outstanding total debt at September 30, 2014 of $1,053.7, of which 62% has a fixed weighted average interest rate of 3.06% and the remaining 38% constituted principally commercial paper issued by the Company that currently has an interest rate of less than 0.5%. The Company periodically considers entering into derivative financial instruments contracts to reduce interest rate risk exposure.

Diesel Fuel Hedges

The Company uses independent freight carriers to deliver its products. These carriers currently charge the Company a basic rate per mile that is currently subject to a mileage surcharge for diesel fuel price increases. During 2013 and 2014, the Company entered into hedge agreements with financial counterparties to mitigate the volatility of diesel fuel prices and related fuel surcharges, and not to speculate in the future price of diesel fuel. Under the hedge agreements, the Company agreed to pay a fixed price per gallon of diesel fuel determined at the time the agreements were executed and to receive a floating rate payment reflecting the variable common carriers’ mileage surcharge. The floating rate payment is determined on a monthly basis based on the average price of the Department of Energy’s Diesel Fuel Index during the applicable month and is designed to offset any increase or decrease in fuel surcharges that the Company pays to it common carriers. The agreements cover approximately 57% of the Company’s 2014 diesel fuel requirements and are expected to cover approximately 63% of the Company’s estimated diesel fuel requirements for 2015. These diesel fuel hedge agreements qualify for hedge accounting. Therefore, changes in the fair value of such agreements are recorded under Accumulated Other Comprehensive Income on the balance sheet.

Foreign Currency

The Company is subject to exposure from fluctuations in foreign currency exchange rates, primarily U.S. Dollar/Euro, U.S. Dollar/British Pound, U.S. Dollar/Canadian Dollar, U.S. Dollar/Mexican Peso, U.S. Dollar/Australian Dollar, U.S. Dollar/Brazilian Real and U.S. Dollar/Chinese Yuan.

The Company, from time to time, enters into forward exchange contracts to reduce the impact of foreign exchange rate fluctuations related to anticipated but not yet committed intercompany sales or purchases denominated in U.S. Dollar, Canadian Dollar, British Pound and Euro. The Company has entered into forward exchange contracts to protect itself from the risk that, due to changes in currency exchange rates, it would be adversely affected by net cash outflows.

Equity Derivatives

The Company has entered into equity derivative contracts covering its stock in order to minimize liability resulting from changes in the quoted fair values of such stock to participants in its Executive Deferred Compensation Plan who have investments under that Plan in a notional Company stock fund. These equity derivative contracts are typically settled in cash. Since the equity derivatives do not qualify for hedge accounting, the Company is required to mark the contracts to market throughout the life of the contracts and record changes in fair value in the consolidated statement of income.

25

ITEM 4. CONTROLS AND PROCEDURES

a) Evaluation of Disclosure Controls and Procedures

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) at the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures, as of the end of the period covered by this report, are effective to provide reasonable assurance that the information required to be disclosed by the Company in reports filed under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the rules and forms of the United States Securities and Exchange Commission (“the Commission”), and (ii) accumulated and communicated to the Company’s management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding the disclosure.

b) Change in Internal Control over Financial Reporting

No change in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the Company’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

CAUTIONARY NOTE ON FORWARD-LOOKING INFORMATION

This report contains forward-looking statements, including, among others, statements relating to sales and earnings growth; the effect of product mix; volume growth, including the effects of new product launches into new and existing categories; the impact of competitive actions in the laundry detergent category; other effects of competition; consumer demand and spending; earnings per share; gross margin changes; trade and marketing spending; marketing expense as a percentage of net sales; cost savings programs; the Company’s hedge programs; the impact of foreign exchange and commodity price fluctuations; the Company’s share repurchase programs; the effective tax rate; the impact of tax audits; tax changes; environmental and regulatory matters; the effect of the credit environment on the Company’s liquidity and capital expenditures; the Company’s fixed rate debt; compliance with the minimum interest coverage ratio requirement and the maximum leverage ratio requirement under the Credit Agreement; sufficiency of cash flows from operations; the Company’s current and anticipated future borrowing capacity to meet capital expenditure program costs; payment of dividends; actual and expected cash contributions to pension plans; and termination settlement expenses related to international pension plans. These statements represent the intentions, plans, expectations and beliefs of the Company, and are subject to risks, uncertainties and other factors, many of which are outside the Company’s control and could cause actual results to differ materially from such forward-looking statements. Factors that might cause such differences include a decline in market growth, retailer distribution and consumer demand (as a result of, among other things, political, economic and marketplace conditions and events); unanticipated increases in raw material and energy prices; adverse developments affecting the financial condition of major customers and suppliers; competition, including the entrance of The Procter & Gamble Company into the value detergent category; changes in marketing and promotional spending; growth or declines in various product categories and the impact of customer actions in response to changes in consumer demand and the economy, including increasing shelf space of private label products; consumer and competitor reaction to, and customer acceptance of, new product introductions and features; disruptions in the banking system and financial markets; foreign currency exchange rate fluctuations; the impact of natural disasters on the Company and its customers and suppliers, including third party information technology service providers; the acquisition or divestiture of assets; the outcome of contingencies, including litigation, pending regulatory proceedings and environmental matters; and changes in the regulatory environment.

The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the U. S. federal securities laws. You are advised, however, to consult any further disclosures the Company makes on related subjects in its filings with the Commission.

PART II – OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

General

The Company, in the ordinary course of its business, is the subject of, or party to, various pending or threatened legal actions. Litigation is subject to many uncertainties, and the outcome of certain individual litigated matters may not be reasonably predictable and any related damages may not be estimable. Some litigation matters could result in an adverse outcome for the Company, and any such adverse outcome could have a material adverse effect on the Company’s business, financial condition, results of operations, and cash flows.

26

ITEM  1A. RISK FACTORS

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Item 1A, “Risk Factors” in the Form 10-K, which could materially affect the Company’s business, financial condition or future results.

ITEM  2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

On January 29, 2014, the Board authorized a new share repurchase program, under which the Company may repurchase up to $500 million of its Common Stock. This share repurchase program replaced the Company’s share repurchase program previously announced on November 5, 2012. In addition, the Board authorized a new evergreen share repurchase program, under which the Company may repurchase, from time to time, Common Stock to reduce or eliminate dilution associated with issuances of Common Stock under the Company’s incentive plans.

As part of the new share repurchase programs, in the first quarter of 2014 the Company entered into accelerated share repurchase (“ASR”) contracts with a commercial bank to purchase $260 million of Common Stock, of which $74 million was purchased under the evergreen program and $186 million was purchased under the share repurchase program.  The Company paid $260 million to the bank and received an initial delivery of approximately 3.5 million shares of Common Stock.   The Company received an additional 0.3 million shares upon settlement of the ASR contracts in the second quarter of 2014.

On May 15, 2014, the Company entered into another ASR contract with a commercial bank to purchase $175 million of Common Stock.  This was purchased under the share repurchase program.  The Company paid $175 million to the bank and received an initial delivery of approximately 2.3 million shares of Common Stock.  The contract was settled in July 2014 and the Company received an additional 0.2 million shares.  As a result of these purchases, there remains $139 million under the share repurchase program.

Period	Total Number of Shares Purchased		Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs		Approximate Dollar Value of Shares that May Yet Be Purchased Under All Programs
7/1/2014 to 7/31/2014		209,994	$	68.75		209,994	$	139,000,000
Total		209,994	$	68.75		209,994

27

ITEM 6. EXHIBITS

	(3.1)	Restated Certificate of Incorporation of the Company, as amended, incorporated by reference to Exhibit 3.2 to the Company’s quarterly report on Form 10-Q for the quarter ended March 27, 2009.
	(3.2)	By-laws of the Company, amended and restated as of February 1, 2012, incorporated by reference to Exhibit 3.2 to the Company’s current report on Form 8-K filed on February 7, 2012.
·	(31.1)	Certification of the Chief Executive Officer of the Company pursuant to Rule 13a-14(a) under the Securities Exchange Act.
·	(31.2)	Certification of the Chief Financial Officer of the Company pursuant to Rule 13a-14(a) under the Securities Exchange Act.
·	(32.1)	Certification of the Chief Executive Officer of the Company pursuant to Rule 13a-14(b) under the Exchange Act and 18 U.S.C. Section 1350.
·	(32.2)	Certification of the Chief Financial Officer of the Company pursuant to Rule 13a-14(b) under the Exchange Act and 18 U.S.C. Section 1350.
	(101)	The following materials from Church & Dwight Co., Inc.’s quarterly report on Form 10-Q for the quarter ended September 30, 2014, formatted in XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Statements of Income for the three and nine months ended September 30, 2014 and September 30, 2013, (ii) Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2014 and September 30, 2013, (iii) Condensed Consolidated Balance Sheets at September 30, 2014 and December 31, 2013, (iv) Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2014 and September 30, 2013, (v) Condensed Consolidated Statements of Stockholders’ Equity for the nine months ended September 30, 2014 and September 30, 2013 and (vi) Notes to Consolidated Financial Statements.

· Indicates documents filed herewith.

28

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		CHURCH & DWIGHT CO., INC.
		(REGISTRANT)
DATE:	November 3, 2014	/s/ Matthew T. Farrell
		MATTHEW T. FARRELL
		CHIEF FINANCIAL OFFICER
DATE:	November 3, 2014	/s/ Steven J. Katz
		STEVEN J. KATZ
		VICE PRESIDENT AND
		CONTROLLER
		(PRINCIPAL ACCOUNTING OFFICER)

29

EXHIBIT INDEX

	(3.1)	Restated Certificate of Incorporation of the Company, as amended, incorporated by reference to Exhibit 3.2 to the Company’s quarterly report on Form 10-Q for the quarter ended March 27, 2009.
	(3.2)	By-laws of the Company, amended and restated as of February 1, 2012, incorporated by reference to Exhibit 3.2 to the Company’s current report on Form 8-K filed on February 7, 2012.
·	(31.1)	Certification of the Chief Executive Officer of the Company pursuant to Rule 13a-14(a) under the Securities Exchange Act.
·	(31.2)	Certification of the Chief Financial Officer of the Company pursuant to Rule 13a-14(a) under the Securities Exchange Act.
·	(32.1)	Certification of the Chief Executive Officer of the Company pursuant to Rule 13a-14(b) under the Exchange Act and 18 U.S.C. Section 1350.
·	(32.2)	Certification of the Chief Financial Officer of the Company pursuant to Rule 13a-14(b) under the Exchange Act and 18 U.S.C. Section 1350.
	(101)	The following materials from Church & Dwight Co., Inc.’s quarterly report on Form 10-Q for the quarter ended September 30, 2014, formatted in XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Statements of Income for the three and nine months ended September 30, 2014 and September 30, 2013, (ii) Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2014 and September 30, 2013, (iii) Condensed Consolidated Balance Sheets at September 30, 2014 and December 31, 2013, (iv) Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2014 and September 30, 2013, (v) Condensed Consolidated Statements of Stockholders’ Equity for the nine months ended September 30, 2014 and September 30, 2013 and (vi) Notes to Consolidated Financial Statements.

· Indicates documents filed herewith.

30

EX-31.1

Exhibit 31.1

CERTIFICATIONS

I, James R. Craigie, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Church & Dwight Co., Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on our evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	November 3, 2014	/s/ James R. Craigie
		James R. Craigie
		Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATIONS

I, Matthew T. Farrell, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Church & Dwight Co., Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on our evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	November 3, 2014	/s/ Matthew T. Farrell
		Matthew T. Farrell
		Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

RULE 13a-14(b) UNDER THE SECURITIES EXCHANGE ACT AND

18 U.S.C. SECTION 1350

I, James R. Craigie, Chief Executive Officer of Church & Dwight Co., Inc. (the “Company”), hereby certify that, based on my knowledge:

1. The Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2014 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:	/s/ James R. Craigie
	James R. Craigie
	Chief Executive Officer
Dated:	November 3, 2014

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

RULE 13a-14(b) UNDER THE SECURITIES EXCHANGE ACT AND

18 U.S.C. SECTION 1350

I, Matthew T. Farrell, Chief Financial Officer of Church & Dwight Co., Inc. (the “Company”), hereby certify that, based on my knowledge:

1. The Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2014 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:	/s/ Matthew T. Farrell
	Matthew T. Farrell
	Chief Financial Officer
Dated:	November 3, 2014

XML

Segments (Tables)

9 Months Ended

Sep. 30, 2014

Segment Reporting [Abstract]

Segment Net Sales and Income Before Income Taxes

Segment Net Sales and Income before Income Taxes for the three and nine months ended September 30, 2014 and September 30, 2013 are as follows:

	Consumer		Consumer
	Domestic		International		SPD		Corporate(3)		Total
Net Sales(1)
Third Quarter 2014	$	627.2	$	136.2	$	78.4	$	0.0	$	841.8
Third Quarter 2013		605.3		134.5		65.0		0.0		804.8
First Nine Months of 2014	$	1,819.4	$	396.6	$	216.1	$	0.0	$	2,432.1
First Nine Months of 2013		1,790.8		396.5		184.4		0.0		2,371.7
Income before Income Taxes(2)
Third Quarter 2014	$	141.4	$	15.0	$	13.4	$	3.4	$	173.2
Third Quarter 2013		136.0		15.5		9.8		1.9		163.2
First Nine Months of 2014	$	376.0	$	47.5	$	33.5	$	7.9	$	464.9
First Nine Months of 2013		383.2		53.0		21.0		1.4		458.6

⁽¹⁾ Intersegment sales from Consumer International to Consumer Domestic were $0.3 and $0.7 for the quarters ended September 30, 2014 and September 30, 2013, respectively, and were $0.8 and $1.9 for the nine months ended September 30, 2014 and September 30, 2013, respectively.

⁽²⁾ In determining Income before Income Taxes, interest expense, investment earnings and other income (expense) were allocated among segments based upon each segment’s relative operating profit.

⁽³⁾ Corporate consists of equity in earnings (losses) of affiliates from Armand, ArmaKleen and Natronx.

Product Line Revenues From External Customers

Product line revenues from external customers are as follows:

	Three Months Ended				Nine Months Ended
	September 30,		September 30,		September 30,		September 30,
	2014		2013		2014		2013
Household Products	$	379.5	$	369.0	$	1,087.2	$	1,081.8
Personal Care Products		247.7		236.3		732.2		709.0
Total Consumer Domestic		627.2		605.3		1,819.4		1,790.8
Total Consumer International		136.2		134.5		396.6		396.5
Total SPD		78.4		65.0		216.1		184.4
Total Consolidated Net Sales	$	841.8	$	804.8	$	2,432.1		2,371.7

XML

Fair Values of Net Assets Acquired (Details) (USD $) In Millions, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Business Acquisition [Line Items]
Goodwill	$ 1,325.0	$ 1,222.2
Lil Drug Store Brands
Business Acquisition [Line Items]
Inventory and other working capital	3.6
Property, plant and equipment	0.7
Tradenames and other intangibles	109.0
Goodwill	102.8
Purchase Price	$ 216.1

XML

Assumptions Used in Valuation of Issued Stock Options (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Risk-free interest rate	2.00%	1.70%	2.00%	1.40%
Expected life in Years	6 years 1 month 6 days	6 years 1 month 6 days	6 years 2 months 12 days	6 years 2 months 12 days
Expected volatility	20.40%	21.20%	20.40%	21.20%
Dividend Yield	1.80%	1.80%	1.80%	1.80%

XML

Segment Net Sales and Income Before Income Taxes (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended				9 Months Ended
	Sep. 30, 2014		Sep. 30, 2013		Sep. 30, 2014		Sep. 30, 2013
Segment Reporting Information [Line Items]
Net Sales	$ 841.8	[1]	$ 804.8	[1]	$ 2,432.1	[1]	$ 2,371.7	[1]
Income before Income Taxes	173.2	[2]	163.2	[2]	464.9	[2]	458.6	[2]
Operating Segments | Consumer Domestic
Segment Reporting Information [Line Items]
Net Sales	627.2	[1]	605.3	[1]	1,819.4	[1]	1,790.8	[1]
Income before Income Taxes	141.4	[2]	136.0	[2]	376.0	[2]	383.2	[2]
Operating Segments | Consumer International
Segment Reporting Information [Line Items]
Net Sales	136.2	[1]	134.5	[1]	396.6	[1]	396.5	[1]
Income before Income Taxes	15.0	[2]	15.5	[2]	47.5	[2]	53.0	[2]
Operating Segments | Specialty Products
Segment Reporting Information [Line Items]
Net Sales	78.4	[1]	65.0	[1]	216.1	[1]	184.4	[1]
Income before Income Taxes	13.4	[2]	9.8	[2]	33.5	[2]	21.0	[2]
Corporate
Segment Reporting Information [Line Items]
Net Sales	0	[1],[3]	0	[1],[3]	0	[1],[3]	0	[1],[3]
Income before Income Taxes	$ 3.4	[2],[3]	$ 1.9	[2],[3]	$ 7.9	[2],[3]	$ 1.4	[2],[3]

[1] Intersegment sales from Consumer International to Consumer Domestic were $0.3 and $0.7 for the quarters ended September 30, 2014 and September 30, 2013, respectively, and were $0.8 and $1.9 for the nine months ended September 30, 2014 and September 30, 2013, respectively.

[2] In determining Income before Income Taxes, interest expense, investment earnings and other income (expense) were allocated among segments based upon each segment’s relative operating profit.

[3] Corporate consists of equity in earnings (losses) of affiliates from Armand, ArmaKleen and Natronx.

XML

Amortizable Intangible Assets (Details) (USD $) In Millions, unless otherwise specified					9 Months Ended				9 Months Ended				9 Months Ended				9 Months Ended
	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2014 Trade names	Dec. 31, 2013 Trade names	Sep. 30, 2014 Trade names Minimum	Sep. 30, 2014 Trade names Maximum	Sep. 30, 2014 Customer Relationships	Dec. 31, 2013 Customer Relationships	Sep. 30, 2014 Customer Relationships Minimum	Sep. 30, 2014 Customer Relationships Maximum	Sep. 30, 2014 Patents	Dec. 31, 2013 Patents	Sep. 30, 2014 Patents Minimum	Sep. 30, 2014 Patents Maximum	Sep. 30, 2014 Noncompete Agreements	Dec. 31, 2013 Noncompete Agreements	Sep. 30, 2014 Noncompete Agreements Minimum	Sep. 30, 2014 Noncompete Agreements Maximum
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 652.1	$ 544.7	$ 254.8	$ 166.8			$ 347.3	$ 333.0			$ 48.6	$ 43.5			$ 1.4	$ 1.4
Accumulated Amortization	(234.3)	(207.0)	(80.1)	(73.9)			(114.9)	(100.4)			(37.9)	(31.4)			(1.4)	(1.3)
Net	$ 417.8	$ 337.7	$ 174.7	$ 92.9			$ 232.4	$ 232.6			$ 10.7	$ 12.1			$ 0	$ 0.1
Amortization Period (Years)					3 years	20 years			15 years	20 years			4 years	20 years			5 years	10 years

XML

Summary of Option Activity (Details) (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Beginning Balance, Options			8.8
Granted, Options	0	0	1.1	1.6
Exercised, Options			(1.0)
Cancelled, Options			(0.1)
Ending Balance, Options	8.8		8.8
Exercisable at September 30, 2014, Options	4.5		4.5
Beginning Balance, Weighted-Average Exercise Price			$ 39.47
Granted, Weighted-Average Exercise Price			$ 69.60
Exercised, Weighted-Average Exercise Price			$ 24.23
Cancelled, Weighted-Average Exercise Price			$ 55.32
Ending Balance, Weighted-Average Exercise Price	$ 44.90		$ 44.90
Exercisable at September 30, 2014, Weighted-Average Exercise Price	$ 29.79		$ 29.79
Outstanding at September 31, 2014, Weighted-Average Remaining Contractual Term, years			6 years 3 months 18 days
Exercisable at September 31, 2014, Weighted-Average Remaining Contractual Term, years			4 years 3 months 18 days
Outstanding at September 30, 2014, Aggregate Intrinsic Value	$ 222.1		$ 222.1
Exercisable at September 30, 2014, Aggregate Intrinsic Value	$ 182.5		$ 182.5

XML

Goodwill and Other Intangibles, Net (Tables)

9 Months Ended

Sep. 30, 2014

Goodwill And Intangible Assets Disclosure [Abstract]

Amortizable Intangible Assets

The following table provides information related to the carrying value of all intangible assets, other than goodwill:

	September 30, 2014								December 31, 2013
	Gross							Amortization	Gross
	Carrying		Accumulated					Period	Carrying		Accumulated
	Amount		Amortization			Net		(Years)	Amount		Amortization			Net
Amortizable intangible assets:
Tradenames	$	254.8	$	(80.1	)	$	174.7	3-20	$	166.8	$	(73.9	)	$	92.9
Customer Relationships		347.3		(114.9	)		232.4	15-20		333.0		(100.4	)		232.6
Patents/Formulas		48.6		(37.9	)		10.7	4-20		43.5		(31.4	)		12.1
Non Compete Agreement		1.4		(1.4	)		0.0	5-10		1.4		(1.3	)		0.1
Total	$	652.1	$	(234.3	)	$	417.8		$	544.7	$	(207.0	)	$	337.7

Indefinite Lived Intangible Assets

Indefinite lived intangible assets - Carrying value

	September 30,		December 31,
	2014		2013
Tradenames	$	865.3	$	866.6

Carrying Amount of Goodwill

The carrying amount of goodwill as of September 30, 2014 and December 31, 2013, respectively, is as follows:

	Consumer		Consumer		Specialty
	Domestic		International		Products		Total
Balance December 31, 2013	$	1,154.8	$	47.2	$	20.2	$	1,222.2
Lil' Drug Store Brands acquired goodwill		102.8		0.0		0.0		102.8
Balance September 30, 2014	$	1,257.6	$	47.2	$	20.2	$	1,325.0

XML

Goodwill and Other Intangibles, Net - Additional Information (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended		3 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Jun. 30, 2014 Consumer Domestic
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Impairment charge of intangible asset			$ 5.6	$ 1.1	$ 5.0
Amortization expense of intangible assets	7.5	7.0	22.7	21.5
Estimated amortization expense, 2014	31.6		31.6
Estimated amortization expense, 2015	35.0		35.0
Estimated amortization expense, 2016	35.0		35.0
Estimated amortization expense, 2017	35.0		35.0
Estimated amortization expense, 2018	35.0		35.0
Estimated amortization expense, 2019	$ 35.0		$ 35.0

XML

Segment Net Sales and Income Before Income Taxes (Parenthetical) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended				9 Months Ended
	Sep. 30, 2014		Sep. 30, 2013		Sep. 30, 2014		Sep. 30, 2013
Segment Reporting Information [Line Items]
Net Sales	$ 841.8	[1]	$ 804.8	[1]	$ 2,432.1	[1]	$ 2,371.7	[1]
Intersegment Eliminations
Segment Reporting Information [Line Items]
Net Sales	$ 0.3		$ 0.7		$ 0.8		$ 1.9

[1] Intersegment sales from Consumer International to Consumer Domestic were $0.3 and $0.7 for the quarters ended September 30, 2014 and September 30, 2013, respectively, and were $0.8 and $1.9 for the nine months ended September 30, 2014 and September 30, 2013, respectively.

XML

Segments

9 Months Ended

Sep. 30, 2014

Segment Reporting [Abstract]

Segments

17. Segments

Segment Information

The Company operates three reportable segments: Consumer Domestic, Consumer International and Specialty Products Division (“SPD”). These segments are determined based on differences in the nature of products and organizational and ownership structures. The Company also has a Corporate segment.

Segment revenues are derived from the sale of the following products:

Segment	Products
Consumer Domestic	Household and personal care products
Consumer International	Primarily personal care products
SPD	Specialty chemical products

The Corporate segment income consists of equity in earnings (losses) of affiliates. As of September 30, 2014, the Company held 50% ownership interests in each of Armand and ArmaKleen, respectively, and a one-third ownership interest in Natronx. The Company’s equity in earnings (losses) of Armand, ArmaKleen and Natronx for the three and nine months ended September 30, 2014 and September 30, 2013 are included in the Corporate segment.

Some of the subsidiaries that are included in the Consumer International segment manufacture and sell personal care products to the Consumer Domestic segment. These sales are eliminated from the Consumer International segment results set forth in the table below.

Segment Net Sales and Income before Income Taxes for the three and nine months ended September 30, 2014 and September 30, 2013 are as follows:

	Consumer		Consumer
	Domestic		International		SPD		Corporate(3)		Total
Net Sales(1)
Third Quarter 2014	$	627.2	$	136.2	$	78.4	$	0.0	$	841.8
Third Quarter 2013		605.3		134.5		65.0		0.0		804.8
First Nine Months of 2014	$	1,819.4	$	396.6	$	216.1	$	0.0	$	2,432.1
First Nine Months of 2013		1,790.8		396.5		184.4		0.0		2,371.7
Income before Income Taxes(2)
Third Quarter 2014	$	141.4	$	15.0	$	13.4	$	3.4	$	173.2
Third Quarter 2013		136.0		15.5		9.8		1.9		163.2
First Nine Months of 2014	$	376.0	$	47.5	$	33.5	$	7.9	$	464.9
First Nine Months of 2013		383.2		53.0		21.0		1.4		458.6

⁽¹⁾ Intersegment sales from Consumer International to Consumer Domestic were $0.3 and $0.7 for the quarters ended September 30, 2014 and September 30, 2013, respectively, and were $0.8 and $1.9 for the nine months ended September 30, 2014 and September 30, 2013, respectively.

⁽²⁾ In determining Income before Income Taxes, interest expense, investment earnings and other income (expense) were allocated among segments based upon each segment’s relative operating profit.

⁽³⁾ Corporate consists of equity in earnings (losses) of affiliates from Armand, ArmaKleen and Natronx.

Product line revenues from external customers are as follows:

	Three Months Ended				Nine Months Ended
	September 30,		September 30,		September 30,		September 30,
	2014		2013		2014		2013
Household Products	$	379.5	$	369.0	$	1,087.2	$	1,081.8
Personal Care Products		247.7		236.3		732.2		709.0
Total Consumer Domestic		627.2		605.3		1,819.4		1,790.8
Total Consumer International		136.2		134.5		396.6		396.5
Total SPD		78.4		65.0		216.1		184.4
Total Consolidated Net Sales	$	841.8	$	804.8	$	2,432.1		2,371.7

Household Products include laundry, deodorizing, and cleaning products. Personal Care Products include condoms, pregnancy kits, oral care products, skin care products and gummy dietary supplements.

XML

Carrying Amounts and Estimated Fair Values of Other Financial Instruments (Parenthetical) (Details)	Sep. 30, 2014	Dec. 31, 2013
2.875% Senior notes due October 1, 2022
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate of debt	2.875%	2.875%
2.875% Senior notes due October 1, 2022 | Fair Value, Inputs, Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate of debt	2.875%	2.875%
3.35% Senior Notes Due December 15, 2015
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate of debt	3.35%	3.35%
3.35% Senior Notes Due December 15, 2015 | Fair Value, Inputs, Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate of debt	3.35%	3.35%

XML

Components of Property, Plant and Equipment (Details) (USD $) In Millions, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Property, Plant and Equipment [Line Items]
Gross Property, Plant and Equipment	$ 1,107.5	$ 1,067.2
Less accumulated depreciation and amortization	511.7	473.1
Net Property, Plant and Equipment	595.8	594.1
Land
Property, Plant and Equipment [Line Items]
Gross Property, Plant and Equipment	25.6	25.7
Building and Building Improvements
Property, Plant and Equipment [Line Items]
Gross Property, Plant and Equipment	281.1	280.4
Machinery and Equipment
Property, Plant and Equipment [Line Items]
Gross Property, Plant and Equipment	596.1	577.5
Software
Property, Plant and Equipment [Line Items]
Gross Property, Plant and Equipment	84.1	83.0
Office equipment and other assets
Property, Plant and Equipment [Line Items]
Gross Property, Plant and Equipment	61.4	57.7
Construction in progress
Property, Plant and Equipment [Line Items]
Gross Property, Plant and Equipment	$ 59.2	$ 42.9

XML

Benefit Plans (Tables)

9 Months Ended

Sep. 30, 2014

Compensation And Retirement Disclosure [Abstract]

Components of Net Periodic Benefit Cost

The following tables provide information regarding the net periodic benefit costs for the Company’s international pension plans and domestic and international nonpension postretirement plans:

	Pension Costs						Pension Costs
	Three Months ended						Nine Months Ended
	September 30,			September 30,			September 30,			September 30,
	2014			2013			2014			2013
Components of Net Periodic Benefit Cost:
Service cost	$	0.2		$	0.3		$	0.6		$	0.9
Interest cost		1.1			0.9			3.3			2.9
Expected return on plan assets		(1.6	)		(1.1	)		(4.6	)		(3.1	)
Amortization of prior service cost		0.6			0.3			0.8			0.7
Net periodic benefit cost (income)	$	0.3		$	0.4		$	0.1		$	1.4
	Nonpension						Nonpension
	Postretirement Costs						Postretirement Costs
	Three Months Ended						Nine Months Ended
	September 30,			September 30,			September 30,			September 30,
	2014			2013			2014			2013
Components of Net Periodic Benefit Cost:
Service cost	$	0.1		$	0.1		$	0.2		$	0.3
Interest cost		0.3			0.2			0.8			0.8
Amortization of prior service cost		(0.4	)		(0.4	)		(1.1	)		(0.6	)
Net periodic benefit cost (income)	$	0.0		$	(0.1	)	$	(0.1	)	$	0.5

XML

Derivative Instruments and Risk Management - Additional Information (Details)	9 Months Ended
	Sep. 30, 2014
Derivative Instruments And Hedging Activities Disclosure [Abstract]
Derivatives, determination of fair value	The fair values of the derivative instruments disclosed above were measured based on Level 2 inputs

XML

Related Party Transactions - Additional Information (Details) (USD $) In Millions, unless otherwise specified							3 Months Ended
	Sep. 30, 2014 Equity Method Investee Armand Products Company	Sep. 30, 2013 Equity Method Investee Armand Products Company	Sep. 30, 2014 Equity Method Investee Armakleen Company	Sep. 30, 2013 Equity Method Investee Armakleen Company	Sep. 30, 2014 Equity Method Investee Natronx LLC	Sep. 30, 2013 Equity Method Investee Natronx LLC	Jun. 30, 2013 Affiliated Entity
Related Party Transaction [Line Items]
Percentage of ownership interest	50.00%	50.00%	50.00%	50.00%	33.33%	33.33%
Impairment charge on investment							$ 3.2

XML

Summary of Short-Term Borrowings and Long-Term Debt (Parenthetical) (Details)	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
2.875% Senior notes due October 1, 2022
Debt Instrument [Line Items]
Interest rate of debt	2.875%	2.875%
Maturity date of debt	Oct. 01, 2022	Oct. 01, 2022
3.35% Senior Notes Due December 15, 2015
Debt Instrument [Line Items]
Interest rate of debt	3.35%	3.35%
Maturity date of debt	Dec. 15, 2015	Dec. 15, 2015

XML

Schedule of Share Based Compensation Stock Options (Details) (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Intrinsic Value of Stock Options Exercised	$ 7.3	$ 5.1	$ 44.5	$ 31.0
Stock Compensation Expense Related to Stock Option Awards	1.7	1.9	13.5	13.3
Issued Stock Options	0	0	1.1	1.6
Weighted Average Fair Value of Stock Options issued (per share)	$ 12.76	$ 11.31	$ 12.84	$ 10.90
Fair Value of Stock Options Issued	$ 0.1	$ 0.5	$ 14.7	$ 17.8

XML

Basis of Presentation

9 Months Ended

Sep. 30, 2014

Accounting Policies [Abstract]

Basis of Presentation

1. Basis of Presentation

The condensed consolidated balance sheets as of September 30, 2014 and December 31, 2013, the condensed consolidated statements of income and comprehensive income for the three and nine months ended September 30, 2014 and September 30, 2013, and the condensed consolidated statements of cash flow and stockholders’ equity for the nine months ended September 30, 2014 and September 30, 2013 have been prepared by Church & Dwight Co., Inc. (the “Company”). In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position at September 30, 2014 and results of operations and cash flow for all periods presented have been made.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles (“GAAP”) have been condensed or omitted. These condensed consolidated financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013 (the “Form 10-K”). The results of operations for the period ended September 30, 2014 are not necessarily indicative of the operating results for the full year.

The Company incurred research and development expenses in the third quarter of 2014 and 2013 of $14.8 and $16.3, respectively. The Company incurred research and development expenses in the first nine months of 2014 and 2013 of $42.3 and $45.0, respectively. These expenses are included in selling, general and administrative expenses.

XML

Components of Changes in Accumulated Other Comprehensive Income (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014		Sep. 30, 2013
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance			$ 0.2		$ 2.5
Other comprehensive income before reclassifications			(13.4)		(7.0)
Amounts reclassified to consolidated statement of income	(0.2)	(0.1)	(0.6)	[1],[2]	0.2	[1],[2]
Tax benefit (expense)			(0.1)
Other comprehensive income (loss)	(18.4)	7.5	(14.1)		(6.8)
Ending balance	(13.9)	(4.3)	(13.9)		(4.3)
Foreign Currency Adjustments
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance			12.7		22.8
Other comprehensive income before reclassifications			(14.8)		(7.0)
Amounts reclassified to consolidated statement of income			0	[1],[2]	0	[1],[2]
Tax benefit (expense)			0
Other comprehensive income (loss)			(14.8)		(7.0)
Ending balance	(2.1)	15.8	(2.1)		15.8
Defined Benefit Plans
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance			(13.0)		(20.5)
Other comprehensive income before reclassifications			1.0		0
Amounts reclassified to consolidated statement of income			0	[1],[2]	0.2	[1],[2]
Tax benefit (expense)			(0.3)
Other comprehensive income (loss)			0.7		0.2
Ending balance	(12.3)	(20.3)	(12.3)		(20.3)
Derivative Agreements
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance			0.5		0.2
Other comprehensive income before reclassifications			0.4		0
Amounts reclassified to consolidated statement of income			(0.6)	[1],[2]	0	[1],[2]
Tax benefit (expense)			0.2
Other comprehensive income (loss)			0		0
Ending balance	$ 0.5	$ 0.2	$ 0.5		$ 0.2

[1] Amounts classified to cost of sales and selling, general and administrative expenses.

[2] The Company reclassified a gain of $0.2 and $0.1 out of AOCI to the consolidated statement of income during the three months ended September 30, 2014 and 2013, respectively.

XML

Depreciation and Interest Charges on Property, Plant and Equipment (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Property Plant And Equipment [Abstract]
Depreciation and amortization on PP&E	$ 13.9	$ 14.1	$ 43.3	$ 44.9
Interest charges capitalized (in construction in progress)	$ 0.2	$ 0.1	$ 0.5	$ 0.3

XML

Stock Based Compensation Plans (Tables)

9 Months Ended

Sep. 30, 2014

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Summary of Option Activity

The following table provides a summary of option activity during the nine months ended September 30, 2014:

						Weighted-
				Weighted-		Average
				Average		Remaining		Aggregate
				Exercise		Contractual		Intrinsic
	Options			Price		Term		Value
Outstanding at December 31, 2013		8.8		$	39.47
Granted		1.1			69.60
Exercised		(1.0	)		24.23
Cancelled		(0.1	)		55.32
Outstanding at September 30, 2014		8.8		$	44.90		6.3	$	222.1
Exercisable at September 30, 2014		4.5		$	29.79		4.3	$	182.5

Information Regarding Intrinsic Value of Stock Options Exercised and Stock Compensation Expense Related to Stock Option Awards

The following table provides information regarding the intrinsic value of stock options exercised and stock compensation expense related to stock option awards:

	Three Months Ended				Nine Months Ended
	September 30,		September 30,		September 30,		September 30,
	2014		2013		2014		2013
Intrinsic Value of Stock Options Exercised	$	7.3	$	5.1	$	44.5	$	31.0
Stock Compensation Expense Related to Stock    Option Awards	$	1.7	$	1.9	$	13.5	$	13.3
Issued Stock Options		0.0		0.0		1.1		1.6
Weighted Average Fair Value of Stock Options    issued (per share)	$	12.76	$	11.31	$	12.84	$	10.90
Fair Value of Stock Options Issued	$	0.1	$	0.5	$	14.7	$	17.8

Assumptions Used in Valuation of Issued Stock Options

The following table provides a summary of the assumptions used in the valuation of issued stock options:

	Three Months Ended						Nine Months Ended
	September 30,			September 30,			September 30,			September 30,
	2014			2013			2014			2013
Risk-free interest rate		2.0	%		1.7	%		2.0	%		1.4	%
Expected life in Years		6.1			6.1			6.2			6.2
Expected volatility		20.4	%		21.2	%		20.4	%		21.2	%
Dividend Yield		1.8	%		1.8	%		1.8	%		1.8	%

XML

Earnings Per Share ("EPS") (Tables)

9 Months Ended

Sep. 30, 2014

Earnings Per Share [Abstract]

Reconciliation of Weighted Average Number of Shares of Common Stock Outstanding

The following table sets forth a reconciliation of the weighted-average number of shares of Common Stock outstanding to the weighted-average number of shares outstanding on a diluted basis:

	Three Months Ended				Nine Months Ended
	September 30,		September 30,		September 30,		September 30,
	2014		2013		2014		2013
Weighted average common shares outstanding -    basic		133.7		138.8		135.5		138.5
Dilutive effect of stock options		2.3		2.5		2.4		2.6
Weighted average common shares outstanding -    diluted		136.0		141.3		137.9		141.1
Antidilutive stock options outstanding		1.2		1.6		1.2		1.6

XML

Indefinite Lived Intangible Assets (Details) (Trade names, USD $) In Millions, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Trade names
Indefinite-lived Intangible Assets [Line Items]
Gross Carrying Value, Trade names	$ 865.3	$ 866.6

XML

Reconciliation of Weighted Average Number of Shares of Common Stock Outstanding (Details) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Earnings Per Share Reconciliation [Abstract]
Weighted average common shares outstanding - basic	133.7	138.8	135.5	138.5
Dilutive effect of stock options	2.3	2.5	2.4	2.6
Weighted average common shares outstanding - diluted	136.0	141.3	137.9	141.1
Antidilutive stock options outstanding	1.2	1.6	1.2	1.6

XML

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2014

Fair Value Disclosures [Abstract]

Carrying Amounts and Estimated Fair Values of Other Financial Instruments

The following table presents the carrying amounts and estimated fair values of the Company’s other financial instruments at September 30, 2014 and December 31, 2013:

		September 30, 2014				December 31, 2013
	Input	Carrying		Fair		Carrying		Fair
	Level	Amount		Value		Amount		Value
Financial Assets:
Cash equivalents	Level 2	$	240.3	$	240.3	$	318.5	$	318.5
Financial Liabilities:
Short-term borrowings	Level 2		404.1		404.1		153.8		153.8
2.875% Senior notes	Level 2		399.7		386.7		399.7		369.8
3.35% Senior notes	Level 2		249.9		258.0		249.8		258.2

XML

Derivative Instruments and Risk Management (Tables)

9 Months Ended

Sep. 30, 2014

Derivative Instruments And Hedging Activities Disclosure [Abstract]

Fair Value of Derivative Instruments and Effect of Such Derivative Instruments on Consolidated Statements of Income and on Other Comprehensive Income

The following tables summarize the fair value of the Company’s derivative instruments and the effect of such derivative instruments on the Company’s Consolidated Statements of Income and on Other Comprehensive Income (“OCI”):

		Notional			Fair Value at
		Amount			September 30,			December 31,
	Balance Sheet Location	September 30, 2014			2014			2013
Derivatives designated as hedging instruments
Asset Derivatives
Diesel fuel contracts	Other current assets	Not Applicable			$	0.0		$	0.3
Foreign exchange contracts	Other current assets	$	68.6			1.7			0.5
Total assets					$	1.7		$	0.8
Liability Derivatives
Diesel fuel contracts	Accounts payable and accrued expenses	5.7 gallons			$	1.1		$	0.0
Total liabilities					$	1.1		$	0.0
Derivatives not designated as hedging      instruments
Asset Derivatives
Equity derivatives	Other current assets	$	26.6		$	0.3		$	2.4
Total assets					$	0.3		$	2.4
Liability Derivatives
Foreign exchange contracts	Accounts payable and accrued expenses	$	1.6		$	0.1		$	0.0
Total liabilities					$	0.1		$	0.0
					Amount of Gain (Loss)
				Recognized in OCI
					from Derivatives
					for the Three Months Ended
	Other Comprehensive Income (Loss)				September 30,			September 30,
	Location				2014			2013
Derivatives designated as hedging instruments
Diesel fuel contracts (net of taxes)	Other comprehensive income (loss)				$	(0.8	)	$	0.2
Foreign exchange contracts (net of taxes)	Other comprehensive income (loss)					1.7			(0.4	)
Total gain (loss) recognized in OCI					$	0.9		$	(0.2	)
					Amount of Gain (Loss)
				Recognized in Income
					for the Three Months Ended
					September 30,			September 30,
	Income Statement Location				2014			2013
Derivatives not designated as hedging     instruments
Equity derivatives	Selling, general and administrative expenses				$	0.1		$	(0.7	)
Foreign exchange contracts	Selling, general and administrative expenses					0.0			(0.1	)
Total gain (loss) recognized in income					$	0.1		$	(0.8	)
					Amount of Gain (Loss)
				Recognized in OCI
					for the Nine Months Ended
	Other Comprehensive Income (Loss)				September 30,			September 30,
	Location				2014			2013
Derivatives designated as hedging instruments
Diesel fuel contracts (net of taxes)	Other comprehensive income (loss)				$	(1.0	)	$	0.0
Foreign exchange contracts (net of taxes)	Other comprehensive income (loss)					1.0			0.0
Total gain (loss) recognized in OCI					$	0.0		$	0.0
					Amount of Gain (Loss)
				Recognized in Income
					for the Nine Months Ended
					September 30,			September 30,
	Income Statement Location				2014			2013
Derivatives not designated as hedging     instruments
Equity derivatives	Selling, general and administrative expenses				$	1.4		$	2.6
Foreign exchange contracts	Selling, general and administrative expenses					0.0			(0.1	)
Total gain (loss) recognized in income					$	1.4		$	2.5

XML

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Statement Of Stockholders Equity [Abstract]
Stock based compensation expense and stock option plan transactions, income tax benefits	$ 14.9	$ 10.0

XML

Acquisition (Tables)

9 Months Ended

Sep. 30, 2014

Business Combinations [Abstract]

Fair Values of Assets Acquired

The preliminary fair values of the net assets acquired are set forth as follows:

	Lil’ Drug Store
Inventory and other working capital	$	3.6
Property, plant and equipment		0.7
Tradenames and other intangibles		109.0
Goodwill		102.8
Purchase Price	$	216.1

XML

Basis of Presentation - Additional Information (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Research and development expenses	$ 14.8	$ 16.3	$ 42.3	$ 45.0

XML

Acquisition - Additional Information (Details) (Lil Drug Store Brands, USD $) In Millions, unless otherwise specified	0 Months Ended	9 Months Ended
	Sep. 19, 2014	Sep. 30, 2014
Business Acquisition [Line Items]
Date of business acquisition		Sep. 19, 2014
Cash consideration	$ 216.1
Approximate annual sales	$ 46.0
Minimum
Business Acquisition [Line Items]
Average life of the amortizable intangible assets, years		5 years
Maximum
Business Acquisition [Line Items]
Average life of the amortizable intangible assets, years		20 years

XML

Product Line Revenues from External Customers (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended				9 Months Ended
	Sep. 30, 2014		Sep. 30, 2013		Sep. 30, 2014		Sep. 30, 2013
Segment Reporting Information [Line Items]
Total Consolidated Net Sales	$ 841.8	[1]	$ 804.8	[1]	$ 2,432.1	[1]	$ 2,371.7	[1]
Operating Segments | Consumer Domestic
Segment Reporting Information [Line Items]
Total Consolidated Net Sales	627.2	[1]	605.3	[1]	1,819.4	[1]	1,790.8	[1]
Operating Segments | Consumer Domestic | Household Products
Segment Reporting Information [Line Items]
Total Consolidated Net Sales	379.5		369.0		1,087.2		1,081.8
Operating Segments | Consumer Domestic | Personal Care Products
Segment Reporting Information [Line Items]
Total Consolidated Net Sales	247.7		236.3		732.2		709.0
Operating Segments | Consumer International
Segment Reporting Information [Line Items]
Total Consolidated Net Sales	136.2	[1]	134.5	[1]	396.6	[1]	396.5	[1]
Operating Segments | Specialty Products
Segment Reporting Information [Line Items]
Total Consolidated Net Sales	$ 78.4	[1]	$ 65.0	[1]	$ 216.1	[1]	$ 184.4	[1]

[1] Intersegment sales from Consumer International to Consumer Domestic were $0.3 and $0.7 for the quarters ended September 30, 2014 and September 30, 2013, respectively, and were $0.8 and $1.9 for the nine months ended September 30, 2014 and September 30, 2013, respectively.

XML

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended				9 Months Ended
	Sep. 30, 2014		Sep. 30, 2013		Sep. 30, 2014		Sep. 30, 2013
Income Statement [Abstract]
Net Sales	$ 841.8	[1]	$ 804.8	[1]	$ 2,432.1	[1]	$ 2,371.7	[1]
Cost of sales	474.3		439.6		1,368.8		1,305.4
Gross Profit	367.5		365.2		1,063.3		1,066.3
Marketing expenses	96.6		99.7		297.8		282.3
Selling, general and administrative expenses	93.7		97.7		288.1		306.4
Income from Operations	177.2		167.8		477.4		477.6
Equity in earnings (losses) of affiliates	3.4		1.9		7.9		1.4
Investment earnings	0.6		0.6		1.7		2.0
Other income (expense), net	(1.1)		(0.1)		(1.6)		(1.4)
Interest expense	(6.9)		(7.0)		(20.5)		(21.0)
Income before Income Taxes	173.2	[2]	163.2	[2]	464.9	[2]	458.6	[2]
Income taxes	57.3		55.3		157.6		156.4
Net Income	$ 115.9		$ 107.9		$ 307.3		$ 302.2
Weighted average shares outstanding - Basic	133.7		138.8		135.5		138.5
Weighted average shares outstanding - Diluted	136.0		141.3		137.9		141.1
Net income per share - Basic	$ 0.87		$ 0.78		$ 2.27		$ 2.18
Net income per share - Diluted	$ 0.85		$ 0.76		$ 2.23		$ 2.14
Cash dividends per share	$ 0.31		$ 0.28		$ 0.93		$ 0.84

[1] Intersegment sales from Consumer International to Consumer Domestic were $0.3 and $0.7 for the quarters ended September 30, 2014 and September 30, 2013, respectively, and were $0.8 and $1.9 for the nine months ended September 30, 2014 and September 30, 2013, respectively.

[2] In determining Income before Income Taxes, interest expense, investment earnings and other income (expense) were allocated among segments based upon each segment’s relative operating profit.

XML

Earning Per Share ("EPS") - Additional Information (Details) (USD $) In Millions, unless otherwise specified	9 Months Ended					0 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014 Accelerated Share Repurchase Contract	Sep. 30, 2014 Evergreen Program	Sep. 30, 2014 Share Repurchase Program	Jan. 29, 2014 Maximum
Equity, Class of Treasury Stock [Line Items]
Share repurchase program, authorized amount						$ 500
Stock purchases, shares			6.4
Payment for share repurchase	435.0	50.0
Accelerated share repurchase agreements, contract value				74	361
Remaining amount for share repurchase program	$ 139

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash Flow From Operating Activities
Net Income	$ 307.3	$ 302.2
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation expense	43.3	44.9
Amortization expense	24.4	23.0
Deferred income taxes	10.5	11.9
Equity in net (earnings) losses of affiliates	(7.9)	(1.4)
Distributions from unconsolidated affiliates	8.4	4.5
Non cash compensation expense	15.0	14.6
Asset impairment charge and other asset write-offs	5.6	1.1
Other	1.1	1.6
Change in assets and liabilities:
Accounts receivable	5.0	(24.4)
Inventories	(10.0)	(14.8)
Other current assets	2.1	(3.5)
Accounts payable and accrued expenses	(2.6)	53.7
Income taxes payable	26.4	(24.5)
Excess tax benefit on stock options exercised	(14.6)	(9.8)
Other operating assets and liabilities, net	(5.3)	(2.5)
Net Cash Provided By Operating Activities	408.7	376.6
Cash Flow From Investing Activities
Additions to property, plant and equipment	(36.2)	(30.3)
Acquisitions, net of cash acquired	(216.1)	0
Investment interest in joint venture	(0.8)	(5.7)
Other	(0.5)	(3.1)
Net Cash Used In Investing Activities	(253.6)	(39.1)
Cash Flow From Financing Activities
Short-term debt borrowings (repayments)	250.4	(99.5)
Proceeds from stock options exercised	24.5	16.2
Excess tax benefit on stock options exercised	14.6	9.8
Payment of cash dividends	(126.0)	(116.3)
Purchase of treasury stock	(435.0)	(50.0)
Lease incentive proceeds	0	10.9
Lease principal payments	(0.9)	(0.8)
Other	0.8	(0.3)
Net Cash Used In Financing Activities	(271.6)	(230.0)
Effect of exchange rate changes on cash and cash equivalents	(10.2)	(5.0)
Net Change In Cash and Cash Equivalents	(126.7)	102.5
Cash and Cash Equivalents at Beginning of Period	496.9	343.0
Cash and Cash Equivalents at End of Period	370.2	445.5
Cash paid during the year for:
Interest (net of amounts capitalized)	14.2	14.9
Income taxes	122.2	171.1
Supplemental disclosure of non-cash investing activities:
Property, plant and equipment expenditures included in Accounts Payable	$ 11.9	$ 4.0

XML

Accounts Payable and Accrued Expenses (Details) (USD $) In Millions, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Accounts Payable and Accrued Liabilities, Current [Abstract]
Trade accounts payable	$ 278.2	$ 256.7
Accrued marketing and promotion costs	125.0	123.7
Accrued wages and related benefit costs	45.5	67.0
Other accrued current liabilities	53.6	47.7
Total	$ 502.3	$ 495.1

XML

Short-Term Borrowings and Long-Term Debt (Tables)

9 Months Ended

Sep. 30, 2014

Debt Disclosure [Abstract]

Components of Short-Term Borrowings and Long-Term Debt

Short-term borrowings and long-term debt consist of the following:

	September 30,			December 31,
	2014			2013
Short-term borrowings
Commercial paper issuances	$	400.0		$	150.0
Various debt due to international banks		4.1			3.8
Total short-term borrowings	$	404.1		$	153.8
Long-term debt
2.875% Senior notes due October 1, 2022	$	400.0		$	400.0
Less: Discount		(0.3	)		(0.3	)
3.35% Senior notes due December 15, 2015		250.0			250.0
Less: Discount		(0.1	)		(0.2	)
Net long-term debt	$	649.6		$	649.5

XML

Benefit Plans - Additional Information (Details) (USD $) In Millions, unless otherwise specified	9 Months Ended		0 Months Ended
	Sep. 30, 2014	May 07, 2014 Foreign Pension Plan, Defined Benefit Employee	May 07, 2014 Foreign Pension Plan, Defined Benefit Minimum	May 07, 2014 Foreign Pension Plan, Defined Benefit Maximum
Defined Benefit Plan Disclosure [Line Items]
Cash contributions to pension plans	$ 2.4
Estimated cash contributions by employer in the remainder of 2014	1.1
Termination of international defined benefit pension plan
Defined benefit plan, number of plan participants		280
Defined benefit plan, plan participants, number of active employees		97
Defined benefit plan, estimated one-time termination benefits in next fiscal year			9	12
Defined benefit plan, estimated one-time termination benefits in next fiscal year, net of tax			$ 7	$ 9

XML

Benefit Plans

9 Months Ended

Sep. 30, 2014

Compensation And Retirement Disclosure [Abstract]

Benefit Plans

14. Benefit Plans

The following tables provide information regarding the net periodic benefit costs for the Company’s international pension plans and domestic and international nonpension postretirement plans:

	Pension Costs						Pension Costs
	Three Months ended						Nine Months Ended
	September 30,			September 30,			September 30,			September 30,
	2014			2013			2014			2013
Components of Net Periodic Benefit Cost:
Service cost	$	0.2		$	0.3		$	0.6		$	0.9
Interest cost		1.1			0.9			3.3			2.9
Expected return on plan assets		(1.6	)		(1.1	)		(4.6	)		(3.1	)
Amortization of prior service cost		0.6			0.3			0.8			0.7
Net periodic benefit cost (income)	$	0.3		$	0.4		$	0.1		$	1.4
	Nonpension						Nonpension
	Postretirement Costs						Postretirement Costs
	Three Months Ended						Nine Months Ended
	September 30,			September 30,			September 30,			September 30,
	2014			2013			2014			2013
Components of Net Periodic Benefit Cost:
Service cost	$	0.1		$	0.1		$	0.2		$	0.3
Interest cost		0.3			0.2			0.8			0.8
Amortization of prior service cost		(0.4	)		(0.4	)		(1.1	)		(0.6	)
Net periodic benefit cost (income)	$	0.0		$	(0.1	)	$	(0.1	)	$	0.5

The Company made cash contributions of approximately $2.4 to its pension plans during the first nine months of 2014. The Company estimates it will be required to make additional cash contributions to its pension plans of approximately $1.1 in the remainder of 2014 to offset 2014 benefit payments and administrative costs in excess of investment returns.

On May 7, 2014, the Company authorized the termination, effective December 31, 2014, of an international defined benefit pension plan under which approximately 280 participants, including 97 active employees, have accrued benefits.  The Company anticipates completing the termination of this plan by the end of the second quarter of 2015, once regulatory approvals are obtained. To effect the termination, the Company estimates, based on May 31, 2014 valuations, that the plan has sufficient assets to purchase annuities for retired participants and make certain deposits to the existing defined contribution plan of active employee participants. The Company estimates that it will incur a one-time non-cash expense of approximately $9 to $12 ($7 to $9 after tax) in 2015 when the plan settlement is completed. This expense is primarily attributable to pension settlement accounting rules which require accelerated recognition of actuarial losses that were to be amortized over the expected benefit lives of participants. The estimated expense is subject to change based on valuations at the actual date of settlement.

XML

Accumulated Other Comprehensive Income (Tables)

9 Months Ended

Sep. 30, 2014

Equity [Abstract]

Components of Changes in Accumulated Other Comprehensive Income

The components of changes in accumulated other comprehensive income (“AOCI”) for the nine months ended September 30, 2014 and September 30, 2013 are as follows:

										Accumulated
	Foreign			Defined						Other
	Currency			Benefit			Derivative			Comprehensive
	Adjustments			Plans			Agreements			Income (Loss)
Balance December 31, 2012	$	22.8		$	(20.5	)	$	0.2		$	2.5
Other comprehensive income before reclassifications		(7.0	)		0.0			0.0			(7.0	)
Amounts reclassified to consolidated statement of    income (a) (b)		0.0			0.2			0.0			0.2
Other comprehensive income (loss)		(7.0	)		0.2			0.0			(6.8	)
Balance September 30, 2013	$	15.8		$	(20.3	)	$	0.2		$	(4.3	)
Balance December 31, 2013	$	12.7		$	(13.0	)	$	0.5		$	0.2
Other comprehensive income before reclassifications		(14.8	)		1.0			0.4			(13.4	)
Amounts reclassified to consolidated statement of    income (a) (b)		0.0			0.0			(0.6	)		(0.6	)
Tax benefit (expense)		0.0			(0.3	)		0.2			(0.1	)
Other comprehensive income (loss)		(14.8	)		0.7			0.0			(14.1	)
Balance September 30, 2014	$	(2.1	)	$	(12.3	)	$	0.5		$	(13.9	)

^(a) Amounts classified to cost of sales and selling, general and administrative expenses.

^(b) The Company reclassified a gain of $0.2 and $0.1 out of AOCI to the consolidated statement of income during the three months ended September 30, 2014 and 2013, respectively.

XML

Related Party Transactions

9 Months Ended

Sep. 30, 2014

Related Party Transactions [Abstract]

Related Party Transactions

16. Related Party Transactions

The following summarizes the balances and transactions between the Company and each of (i) Armand Products Company (“Armand”) and The ArmaKleen Company (“ArmaKleen”), in which the Company holds a 50% ownership interest, and (ii) Natronx, in which the Company holds a one-third ownership interest:

	Armand				ArmaKleen				Natronx
	Nine Months Ended				Nine Months Ended				Nine Months Ended
	September 30,		September 30,		September 30,		September 30,		September 30,		September 30,
	2014		2013		2014		2013		2014		2013
Purchases by Company	$	20.3	$	17.1	$	0.0	$	0.0	$	0.0	$	0.0
Sales by Company	$	0.0	$	0.0	$	0.9	$	1.0	$	1.5	$	1.3
Outstanding Accounts    Receivable	$	0.2	$	0.5	$	0.6	$	0.4	$	0.1	$	0.1
Outstanding Accounts Payable	$	2.8	$	2.0	$	0.0	$	0.0	$	0.0	$	0.0
Administration & Management    Oversight Services (1)	$	1.7	$	1.4	$	1.5	$	1.6	$	0.6	$	0.9

⁽¹⁾ Billed by Company and recorded as a reduction of selling, general and administrative expenses.

The Company recorded a $3.2 impairment charge associated with one of its affiliates in the second quarter of 2013. The charge, recorded in Equity in Earnings (Losses) of Affiliates, is a result of the Company’s assessment of the financial impact from the delay in anticipated discounted cash flows from the affiliate.

XML

Balance and Transactions Between Company and Related Party (Details) (Equity Method Investee, USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2014		Sep. 30, 2013
Armand Products Company
Related Party Transaction [Line Items]
Purchases by Company	$ 20.3		$ 17.1
Sales by Company	0		0
Outstanding Accounts Receivable	0.2		0.5
Outstanding Accounts Payable	2.8		2.0
Administration & Management Oversight Services	1.7	[1]	1.4	[1]
Armakleen Company
Related Party Transaction [Line Items]
Purchases by Company	0		0
Sales by Company	0.9		1.0
Outstanding Accounts Receivable	0.6		0.4
Outstanding Accounts Payable	0		0
Administration & Management Oversight Services	1.5	[1]	1.6	[1]
Natronx LLC
Related Party Transaction [Line Items]
Purchases by Company	0		0
Sales by Company	1.5		1.3
Outstanding Accounts Receivable	0.1		0.1
Outstanding Accounts Payable	0		0
Administration & Management Oversight Services	$ 0.6	[1]	$ 0.9	[1]

[1] Billed by Company and recorded as a reduction of selling, general and administrative expenses.

XML

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (USD $) In Millions	Total	Common Stock	Treasury Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Total Church & Dwight Co., Inc. Stockholders' Equity	Noncontrolling Interest
Beginning Balance at Dec. 31, 2012	$ 2,061.1	$ 146.4	$ (336.1)	$ 318.8	$ 1,929.3	$ 2.5	$ 2,060.9	$ 0.2
Beginning Balance (in shares) at Dec. 31, 2012		146.4	(7.6)
Net Income	302.2	0	0	0	302.2	0	302.2	0
Other comprehensive income	(6.8)	0	0	0	0	(6.8)	(6.8)	0
Cash dividends	(116.3)	0	0	0	(116.3)	0	(116.3)	0
Stock purchases	(50.0)	0	(50.0)	0	0	0	(50.0)	0
Stock purchases (in shares)			(0.9)
Stock based compensation expense and stock option plan transactions, including related income tax benefits	40.5	0	4.4	36.1	0	0	40.5	0
Stock based compensation expense and stock option plan transactions, including related income tax benefits (in shares)			0.8
Ending Balance at Sep. 30, 2013	2,230.7	146.4	(381.7)	354.9	2,115.2	(4.3)	2,230.5	0.2
Ending Balance (in shares) at Sep. 30, 2013		146.4	(7.7)
Beginning Balance at Dec. 31, 2013	2,300.0	146.4	(368.1)	352.9	2,168.5	0.2	2,299.9	0.1
Beginning Balance (in shares) at Dec. 31, 2013		146.4	(7.5)
Net Income	307.3	0	0	0	307.3	0	307.3	0
Other comprehensive income	(14.1)	0	0	0	0	(14.1)	(14.1)	0
Cash dividends	(126.0)	0	0	0	(126.0)	0	(126.0)	0
Stock purchases	(435.0)	0	(435.0)	0	0	0	(435.0)	0
Stock purchases (in shares)			(6.4)
Stock based compensation expense and stock option plan transactions, including related income tax benefits	53.5	0	43.6	9.9	0	0	53.5	0
Stock based compensation expense and stock option plan transactions, including related income tax benefits (in shares)			1.0
Other stock issuances (in shares)		0	0.1
Other stock issuances	1.7	0	1.1	0.6	0	0	1.7	0
Ending Balance at Sep. 30, 2014	$ 2,087.4	$ 146.4	$ (758.4)	$ 363.4	$ 2,349.8	$ (13.9)	$ 2,087.3	$ 0.1
Ending Balance (in shares) at Sep. 30, 2014		146.4	(12.8)

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Statement Of Income And Comprehensive Income [Abstract]
Net Income	$ 115.9	$ 107.9	$ 307.3	$ 302.2
Other comprehensive income, net of tax:
Foreign exchange translation adjustments	(19.3)	7.8	(14.8)	(7.0)
Defined benefit plan adjustments	0	(0.1)	0.7	0.2
Income (loss) from derivative agreements	0.9	(0.2)	0	0
Other comprehensive income (loss)	(18.4)	7.5	(14.1)	(6.8)
Comprehensive income	$ 97.5	$ 115.4	$ 293.2	$ 295.4

XML

Acquisition

9 Months Ended

Sep. 30, 2014

Business Combinations [Abstract]

Acquisition

9. Acquisition

On September 19, 2014, the Company acquired certain feminine care brands, including REPHRESH and REPLENS, from Lil’ Drug Store Products, Inc., (“Lil’ Drug Store Brands Acquisition”) for cash consideration of $216.1. The Company paid for the acquisition with additional debt. The annual sales of the acquired brands are approximately $46.0. These feminine care brands will be managed within the Consumer Domestic and Consumer International segments.

The preliminary fair values of the net assets acquired are set forth as follows:

	Lil’ Drug Store
Inventory and other working capital	$	3.6
Property, plant and equipment		0.7
Tradenames and other intangibles		109.0
Goodwill		102.8
Purchase Price	$	216.1

The life of the amortizable intangible assets recognized from the Lil’ Drug Store Brands Acquisition ranges from 5 - 20 years. Pro forma results are not presented because the impact is not material to the Company’s consolidated financial results.

XML

Document and Entity Information	9 Months Ended
	Sep. 30, 2014	Oct. 29, 2014
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2014
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	Q3
Trading Symbol	CHD
Entity Registrant Name	CHURCH & DWIGHT CO INC /DE/
Entity Central Index Key	0000313927
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		133,774,605

XML

Goodwill and Other Intangibles, Net

9 Months Ended

Sep. 30, 2014

Goodwill And Intangible Assets Disclosure [Abstract]

Goodwill and Other Intangibles, Net

10. Goodwill and Other Intangibles, Net

The following table provides information related to the carrying value of all intangible assets, other than goodwill:

	September 30, 2014								December 31, 2013
	Gross							Amortization	Gross
	Carrying		Accumulated					Period	Carrying		Accumulated
	Amount		Amortization			Net		(Years)	Amount		Amortization			Net
Amortizable intangible assets:
Tradenames	$	254.8	$	(80.1	)	$	174.7	3-20	$	166.8	$	(73.9	)	$	92.9
Customer Relationships		347.3		(114.9	)		232.4	15-20		333.0		(100.4	)		232.6
Patents/Formulas		48.6		(37.9	)		10.7	4-20		43.5		(31.4	)		12.1
Non Compete Agreement		1.4		(1.4	)		0.0	5-10		1.4		(1.3	)		0.1
Total	$	652.1	$	(234.3	)	$	417.8		$	544.7	$	(207.0	)	$	337.7

Indefinite lived intangible assets - Carrying value

	September 30,		December 31,
	2014		2013
Tradenames	$	865.3	$	866.6

During the second quarter of 2014, the Company recorded an impairment charge of $5.0 for an intangible asset related to the Consumer Domestic segment. This charge is included in selling, general and administrative expenses in this segment and was the result of reduced sales and profitability related to the product line. The amount of the charge was determined from estimating that future cash flows would not be sufficient to recover the carrying amount of the asset.

Intangible amortization expense amounted to $7.5 and $7.0 for the third quarter of 2014 and 2013, respectively. Intangible amortization expense amounted to $22.7 and $21.5 for the first nine months of 2014 and 2013, respectively. The Company estimates that intangible amortization expense will be approximately $31.6 in 2014 and approximately $35.0 in each of the next five years.

The carrying amount of goodwill as of September 30, 2014 and December 31, 2013, respectively, is as follows:

	Consumer		Consumer		Specialty
	Domestic		International		Products		Total
Balance December 31, 2013	$	1,154.8	$	47.2	$	20.2	$	1,222.2
Lil' Drug Store Brands acquired goodwill		102.8		0.0		0.0		102.8
Balance September 30, 2014	$	1,257.6	$	47.2	$	20.2	$	1,325.0

The increase in goodwill and amortizable assets is due to the Lil’ Drug Store Brands Acquisition.

The result of the Company’s annual goodwill impairment test, performed in the beginning of the second quarter of 2014, determined that the estimated fair value substantially exceeded the carrying values of all reporting units.

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $) In Millions, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Current Assets
Cash and cash equivalents	$ 370.2	$ 496.9
Accounts receivable, less allowances of $1.5 and $0.8	321.3	330.2
Inventories	261.6	250.5
Deferred income taxes	19.5	16.6
Other current assets	20.2	21.6
Total Current Assets	992.8	1,115.8
Property, Plant and Equipment, Net	595.8	594.1
Equity Investment in Affiliates	24.8	24.5
Tradenames and Other Intangibles, Net	1,283.1	1,204.3
Goodwill	1,325.0	1,222.2
Other Assets	104.3	98.8
Total Assets	4,325.8	4,259.7
Current Liabilities
Short-term borrowings	404.1	153.8
Accounts payable and accrued expenses	502.3	495.1
Income taxes payable	12.0	2.3
Total Current Liabilities	918.4	651.2
Long-term Debt	649.6	649.5
Deferred Income Taxes	490.6	476.0
Deferred and Other Long-term Liabilities	155.8	157.5
Pension, Postretirement and Postemployment Benefits	24.0	25.5
Total Liabilities	2,238.4	1,959.7
Commitments and Contingencies
Stockholders' Equity
Preferred Stock, $1.00 par value, Authorized 2,500,000 shares; none issued	0	0
Common Stock, $1.00 par value, Authorized 300,000,000 shares; 146,427,550 shares issued	146.4	146.4
Additional paid-in capital	363.4	352.9
Retained earnings	2,349.8	2,168.5
Accumulated other comprehensive income (loss)	(13.9)	0.2
Common stock in treasury, at cost: 12,806,896 shares in 2014 and 7,462,913 shares in 2013	(758.4)	(368.1)
Total Church & Dwight Co., Inc. Stockholders' Equity	2,087.3	2,299.9
Noncontrolling interest	0.1	0.1
Total Stockholders' Equity	2,087.4	2,300.0
Total Liabilities and Stockholders' Equity	$ 4,325.8	$ 4,259.7

XML

Property, Plant and Equipment, Net ("PP&E")

9 Months Ended

Sep. 30, 2014

Property Plant And Equipment [Abstract]

Property, Plant and Equipment, Net ("PP&E")

4. Property, Plant and Equipment, Net (“PP&E”)

PP&E consist of the following:

	September 30,		December 31,
	2014		2013
Land	$	25.6	$	25.7
Buildings and improvements		281.1		280.4
Machinery and equipment		596.1		577.5
Software		84.1		83.0
Office equipment and other assets		61.4		57.7
Construction in progress		59.2		42.9
Gross Property, Plant and Equipment		1,107.5		1,067.2
Less accumulated depreciation and amortization		511.7		473.1
Net Property, Plant and Equipment	$	595.8	$	594.1

	Three Months Ended				Nine Months Ended
	September 30,		September 30,		September 30,		September 30,
	2014		2013		2014		2013
Depreciation and amortization on PP&E	$	13.9	$	14.1	$	43.3	$	44.9
Interest charges capitalized (in construction in    progress)	$	0.2	$	0.1	$	0.5	$	0.3

XML

Inventories

9 Months Ended

Sep. 30, 2014

Inventory Disclosure [Abstract]

Inventories

3. Inventories

Inventories consist of the following:

	September 30,		December 31,
	2014		2013
Raw materials and supplies	$	68.4	$	70.2
Work in process		27.0		30.4
Finished goods		166.2		149.9
Total	$	261.6	$	250.5

XML

Commitments, Contingencies and Guarantees

9 Months Ended

Sep. 30, 2014

Commitments And Contingencies Disclosure [Abstract]

Commitments, Contingencies and Guarantees

15. Commitments, Contingencies and Guarantees

Commitments

a. The Company has a partnership with a supplier of raw materials that mines and processes sodium-based mineral deposits. The Company purchases the majority of its sodium-based raw material requirements from the partnership. The partnership agreement for the partnership terminates upon two years’ written notice by either partner. Under the partnership agreement, the Company has an annual commitment to purchase 240,000 tons of sodium-based raw materials at the prevailing market price. With the exception of the Natronx Technologies LLC (“Natronx”) joint venture, in which the Company and the partner supplier are each one-third owners, the Company is not engaged in any other material transactions with the partnership or the partner supplier.

b. As of September 30, 2014, the Company had commitments through 2019 of approximately $231.3. These commitments include the purchase of raw materials, packaging supplies and services from its vendors at market prices to enable the Company to respond quickly to changes in customer orders or requirements, as well as costs associated with licensing and promotion agreements.

c. As of September 30, 2014, the Company had the following guarantees: (i) $4.7 in outstanding letters of credit drawn on several banks which guarantee payment for such things as insurance claims in the event of the Company’s insolvency, (ii) an insolvency protection guarantee of approximately $19.0 to one of its United Kingdom pension plans effective January 1, 2011, and (iii) $3.5 worth of assets subject to guarantees for its Brazil operations for value added tax assessments and labor related cases currently under appeal.

d. On November 8, 2011, the Company acquired a license for certain oral care technology for cash consideration of $4.3. In addition to this initial payment, the Company is required to make advance royalty payments of up to $5.5 upon the launch of a product utilizing the licensed technology, of which $4.3 had been made as of September 30, 2014. The Company is required to make an additional $7.0 license payment upon the approval of certain New Drug Applications by the U.S. Food and Drug Administration for products incorporating the acquired technology.

Environmental matter

e. In 2000, the Company acquired majority ownership in its Brazilian subsidiary, Quimica Geral Do Nordeste S.A. (“QGN”). The acquired operations included an inorganic salt manufacturing plant which began site operations in the late 1970’s. Located on the site were two closed landfills, two active landfills and a pond for the management of process waste streams. In 2009, QGN was advised by the environmental authority in the State of Bahia, the Institute of the Environment (“IMA”), that the plant was discharging contaminants into an adjacent creek. After learning of the discharge, QGN took immediate action to cease the discharge and retained two nationally recognized environmental firms to prepare a site investigation / remedial action (“SI/RA”) report. The SI/RA report was submitted by QGN to IMA in April 2010. The report concluded that the likely sources of the discharge were the failure of the pond and closed landfills. QGN ceased site operations in August 2010. In November 2010, IMA responded to QGN’s recommendation for an additional study by issuing a notification requiring a broad range of remediation measures (the “Remediation Notification”), which included the shutdown and removal of two on-site landfills. In addition, despite repeated discussions with IMA at QGN’s request to consider QGN’s proposed remediation alternatives, in December 2010, IMA imposed a fine of five million Brazilian Real (approximately U.S. $2.0 at current exchange rates) for the discharge of contaminants above allowable limits. The description of the fine included a reference to aggravating factors that may indicate that local “management’s intent” was considered in determining the severity of the fine, which could result in criminal liability for members of local management. In January 2011, QGN filed with IMA an administrative defense to the fine, suspending any enforcement activities pending its defense. IMA has not yet formally responded to QGN’s administrative defense.

With respect to the Remediation Notification, QGN engaged in discussions with IMA during which QGN asserted that a number of the remediation measures, including the removal of the landfills, and the timeframes for implementation were not appropriate and requested that the Remediation Notification be withdrawn. In response, in February 2011, IMA issued a revised Remediation Notification (the “Revised Remediation Notification”) providing for further site analysis by QGN, including further study of the integrity of the landfills. The Revised Remediation Notification did not include a requirement to remove the landfills; however, it did not foreclose the possibility of such a requirement. QGN has responded to the Revised Remediation Notification providing further information regarding the remediation measures, and is in discussions with the Institute of Environment and Waste Management (“INEMA”), successor to IMA, to seek agreement on an appropriate remediation plan. In mid-2011, QGN, consistent with the Revised Remediation Notice, began an additional site investigation and capped the two active landfills. In 2012, QGN drained the waste pond. During the third quarter of 2013, INEMA approved the first step in QGN’s proposed remediation plans, the installation of a trench drain to capture and treat groundwater at the site. Construction of the trench drain began during the first quarter of 2014 and is expected to be completed during the fourth quarter 2014. In June 2014, QGN formally submitted to INEMA a technical report, including a remediation plan for the site and a proposed agreement regarding the fine and QGN’s ongoing obligations at the site. In July 2014, an initial meeting was held with INEMA to review and discuss the report and the proposed agreement. After the meeting QGN has provided additional information regarding the remediation plan in response to requests by INEMA.

As a result of the foregoing events, the Company accrued approximately $3.0 in 2009 and $4.8 in 2010 for remediation, fines and related costs. Since 2009, the costs of remediation activities and foreign exchange rate changes have reduced the accrual by approximately $4.4 to a current amount of $3.4. As a result of INEMA’s approval of the first step in QGN’s remediation plans, the Company does not believe that QGN will be required to remove the landfills. However, it remains reasonably possible that INEMA will require such removal, and the Company could be unsuccessful in appealing such decision. The Company estimates the cost of such landfill removal to be in the range of $30 to $50.

Legal and tax proceedings

f. The Company has recorded liabilities for uncertain income tax positions that, although supportable, may be challenged by tax authorities. The Company’s liabilities for uncertain income tax positions are $4.4 as of September 30, 2014.  The Company does not expect a material change in the liabilities for uncertain income tax positions within the next twelve months.

g. In addition, in conjunction with the Company’s acquisition and divestiture activities, the Company entered into select guarantees and indemnifications of performance with respect to the fulfillment of the Company’s commitments under applicable purchase and sale agreements. The arrangements generally indemnify the buyer or seller for damages associated with breach of contract, inaccuracies in representations and warranties surviving the closing date and satisfaction of liabilities and commitments retained under the applicable contract. Representations and warranties that survive the closing date generally survive for periods up to five years or the expiration of the applicable statutes of limitations. Potential losses under the indemnifications are generally limited to a portion of the original transaction price, or to other lesser specific dollar amounts for select provisions. With respect to sale transactions, the Company also routinely enters into non-competition agreements for varying periods of time. Guarantees and indemnifications with respect to acquisition and divestiture activities, if triggered, could have a materially adverse impact on the Company’s financial condition and results of operations.

h. The Company, in the ordinary course of its business, is the subject of, or party to, various pending or threatened legal and regulatory proceedings. Such proceedings are subject to many uncertainties, and the outcome of certain individual litigated matters and other proceedings, whether actual or threatened, may not be reasonably predictable and any related damages or liability may not be estimable. Certain legal and regulatory proceedings, including those described above, could result in an adverse outcome for the Company, and any such adverse outcome could have a material adverse effect on the Company’s business, financial condition, results of operations and cash flows.

XML

Accounts Payable and Accrued Expenses

9 Months Ended

Sep. 30, 2014

Payables And Accruals [Abstract]

Accounts Payable and Accrued Expenses

11. Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses consist of the following:

	September 30,		December 31,
	2014		2013
Trade accounts payable	$	278.2	$	256.7
Accrued marketing and promotion costs		125.0		123.7
Accrued wages and related benefit costs		45.5		67.0
Other accrued current liabilities		53.6		47.7
Total	$	502.3	$	495.1

XML

Fair Value Measurements

9 Months Ended

Sep. 30, 2014

Fair Value Disclosures [Abstract]

Fair Value Measurements

7. Fair Value Measurements

Fair Value Hierarchy

Accounting guidance on fair value measurements and disclosures establishes a hierarchy that prioritizes the inputs used to measure fair value (generally, assumptions that market participants would use in pricing an asset or liability) based on the quality and reliability of the information provided by the inputs, as follows:

Level 1: Quoted market prices in active markets for identical assets or liabilities.

Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.

Level 3: Unobservable inputs that are not corroborated by market data.

The Company recognizes transfers between input levels as of the actual date of the event. There were no transfers between input levels during the nine months ended September 30, 2014.

Fair Values of Other Financial Instruments

The following table presents the carrying amounts and estimated fair values of the Company’s other financial instruments at September 30, 2014 and December 31, 2013:

		September 30, 2014				December 31, 2013
	Input	Carrying		Fair		Carrying		Fair
	Level	Amount		Value		Amount		Value
Financial Assets:
Cash equivalents	Level 2	$	240.3	$	240.3	$	318.5	$	318.5
Financial Liabilities:
Short-term borrowings	Level 2		404.1		404.1		153.8		153.8
2.875% Senior notes	Level 2		399.7		386.7		399.7		369.8
3.35% Senior notes	Level 2		249.9		258.0		249.8		258.2

The following methods and assumptions were used to estimate the fair value of each class of financial instruments reflected in the Consolidated Balance Sheets:

Cash Equivalents: Cash equivalents consist of highly liquid short-term investments and term bank deposits, which mature within three months. The estimated fair value of the Company’s cash equivalents approximates their carrying value.

Short-Term Borrowings: The carrying amounts of the Company’s unsecured lines of credit and commercial paper issuances approximates fair value because of their short maturities and variable interest rates.

Senior Notes: The Company determines the fair value of its senior notes based on their quoted market value or broker quotes, when possible. In the absence of observable market quotes, the notes are valued using non-binding market consensus prices that the Company seeks to corroborate with observable market data.

XML

Summary of Short-Term Borrowings and Long-Term Debt (Details) (USD $) In Millions, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Debt Instrument [Line Items]
Commercial paper issuances	$ 400.0	$ 150.0
Various debt due to international banks	4.1	3.8
Total short-term borrowings	404.1	153.8
Net long-term debt	649.6	649.5
2.875% Senior notes due October 1, 2022
Debt Instrument [Line Items]
Senior notes	400.0	400.0
Less: Discount	(0.3)	(0.3)
3.35% Senior Notes Due December 15, 2015
Debt Instrument [Line Items]
Senior notes	250.0	250.0
Less: Discount	$ (0.1)	$ (0.2)

XML

Earnings Per Share ("EPS")

9 Months Ended

Sep. 30, 2014

Earnings Per Share [Abstract]

Earnings Per Share ("EPS")

5. Earnings Per Share (“EPS”)

Basic EPS is calculated based on income available to holders of the Company’s common stock (“Common Stock”) and the weighted-average number of shares outstanding during the reported period. Diluted EPS includes additional dilution from potential Common Stock issuable pursuant to the exercise of outstanding stock options.

The following table sets forth a reconciliation of the weighted-average number of shares of Common Stock outstanding to the weighted-average number of shares outstanding on a diluted basis:

	Three Months Ended				Nine Months Ended
	September 30,		September 30,		September 30,		September 30,
	2014		2013		2014		2013
Weighted average common shares outstanding -    basic		133.7		138.8		135.5		138.5
Dilutive effect of stock options		2.3		2.5		2.4		2.6
Weighted average common shares outstanding -    diluted		136.0		141.3		137.9		141.1
Antidilutive stock options outstanding		1.2		1.6		1.2		1.6

On January 29, 2014, the Company’s board of directors (“the Board”) authorized a new share repurchase program, under which the Company may repurchase up to $500 of its common stock (“Common Stock”). This share repurchase program replaced the Company’s share repurchase program previously announced on November 5, 2012. In addition, the Board authorized a new evergreen share repurchase program, under which the Company may repurchase, from time to time, Common Stock to reduce or eliminate dilution associated with issuances of Common Stock under the Company’s incentive plans.

As part of the new share repurchase programs, in the first nine months of 2014 the Company entered into accelerated share repurchase (“ASR”) contracts with a commercial bank to purchase approximately 6.4 million shares of Common Stock for $435, of which $74 was purchased under the evergreen program and $361 was purchased under the share repurchase program.   As a result of these purchases, there remains $139 under the share repurchase program.

XML

Stock Based Compensation Plans

9 Months Ended

Sep. 30, 2014

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Stock Based Compensation Plans

6. Stock Based Compensation Plans

The following table provides a summary of option activity during the nine months ended September 30, 2014:

						Weighted-
				Weighted-		Average
				Average		Remaining		Aggregate
				Exercise		Contractual		Intrinsic
	Options			Price		Term		Value
Outstanding at December 31, 2013		8.8		$	39.47
Granted		1.1			69.60
Exercised		(1.0	)		24.23
Cancelled		(0.1	)		55.32
Outstanding at September 30, 2014		8.8		$	44.90		6.3	$	222.1
Exercisable at September 30, 2014		4.5		$	29.79		4.3	$	182.5

The following table provides information regarding the intrinsic value of stock options exercised and stock compensation expense related to stock option awards:

	Three Months Ended				Nine Months Ended
	September 30,		September 30,		September 30,		September 30,
	2014		2013		2014		2013
Intrinsic Value of Stock Options Exercised	$	7.3	$	5.1	$	44.5	$	31.0
Stock Compensation Expense Related to Stock    Option Awards	$	1.7	$	1.9	$	13.5	$	13.3
Issued Stock Options		0.0		0.0		1.1		1.6
Weighted Average Fair Value of Stock Options    issued (per share)	$	12.76	$	11.31	$	12.84	$	10.90
Fair Value of Stock Options Issued	$	0.1	$	0.5	$	14.7	$	17.8

The following table provides a summary of the assumptions used in the valuation of issued stock options:

	Three Months Ended						Nine Months Ended
	September 30,			September 30,			September 30,			September 30,
	2014			2013			2014			2013
Risk-free interest rate		2.0	%		1.7	%		2.0	%		1.4	%
Expected life in Years		6.1			6.1			6.2			6.2
Expected volatility		20.4	%		21.2	%		20.4	%		21.2	%
Dividend Yield		1.8	%		1.8	%		1.8	%		1.8	%

The fair value of stock options is based upon the Black Scholes option pricing model. The Company determined the stock options’ lives based on historical exercise behavior and their expected volatility and dividend yield based on the historical changes in stock price and dividend payments. The risk free interest rate is based on the yield of an applicable term Treasury instrument.

XML

Derivative Instruments and Risk Management

9 Months Ended

Sep. 30, 2014

Derivative Instruments And Hedging Activities Disclosure [Abstract]

Derivative Instruments and Risk Management

8. Derivative Instruments and Risk Management

The following tables summarize the fair value of the Company’s derivative instruments and the effect of such derivative instruments on the Company’s Consolidated Statements of Income and on Other Comprehensive Income (“OCI”):

		Notional			Fair Value at
		Amount			September 30,			December 31,
	Balance Sheet Location	September 30, 2014			2014			2013
Derivatives designated as hedging instruments
Asset Derivatives
Diesel fuel contracts	Other current assets	Not Applicable			$	0.0		$	0.3
Foreign exchange contracts	Other current assets	$	68.6			1.7			0.5
Total assets					$	1.7		$	0.8
Liability Derivatives
Diesel fuel contracts	Accounts payable and accrued expenses	5.7 gallons			$	1.1		$	0.0
Total liabilities					$	1.1		$	0.0
Derivatives not designated as hedging      instruments
Asset Derivatives
Equity derivatives	Other current assets	$	26.6		$	0.3		$	2.4
Total assets					$	0.3		$	2.4
Liability Derivatives
Foreign exchange contracts	Accounts payable and accrued expenses	$	1.6		$	0.1		$	0.0
Total liabilities					$	0.1		$	0.0
					Amount of Gain (Loss)
				Recognized in OCI
					from Derivatives
					for the Three Months Ended
	Other Comprehensive Income (Loss)				September 30,			September 30,
	Location				2014			2013
Derivatives designated as hedging instruments
Diesel fuel contracts (net of taxes)	Other comprehensive income (loss)				$	(0.8	)	$	0.2
Foreign exchange contracts (net of taxes)	Other comprehensive income (loss)					1.7			(0.4	)
Total gain (loss) recognized in OCI					$	0.9		$	(0.2	)
					Amount of Gain (Loss)
				Recognized in Income
					for the Three Months Ended
					September 30,			September 30,
	Income Statement Location				2014			2013
Derivatives not designated as hedging     instruments
Equity derivatives	Selling, general and administrative expenses				$	0.1		$	(0.7	)
Foreign exchange contracts	Selling, general and administrative expenses					0.0			(0.1	)
Total gain (loss) recognized in income					$	0.1		$	(0.8	)
					Amount of Gain (Loss)
				Recognized in OCI
					for the Nine Months Ended
	Other Comprehensive Income (Loss)				September 30,			September 30,
	Location				2014			2013
Derivatives designated as hedging instruments
Diesel fuel contracts (net of taxes)	Other comprehensive income (loss)				$	(1.0	)	$	0.0
Foreign exchange contracts (net of taxes)	Other comprehensive income (loss)					1.0			0.0
Total gain (loss) recognized in OCI					$	0.0		$	0.0
					Amount of Gain (Loss)
				Recognized in Income
					for the Nine Months Ended
					September 30,			September 30,
	Income Statement Location				2014			2013
Derivatives not designated as hedging     instruments
Equity derivatives	Selling, general and administrative expenses				$	1.4		$	2.6
Foreign exchange contracts	Selling, general and administrative expenses					0.0			(0.1	)
Total gain (loss) recognized in income					$	1.4		$	2.5

The notional amount of a derivative instrument is the nominal or face amount used to calculate payments made on that instrument. The fair values of the derivative instruments disclosed above were measured based on Level 2 inputs (observable market-based inputs or unobservable inputs that are corroborated by market data).

XML

Components Of Net Periodic Benefit Cost (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Pension Costs
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 0.2	$ 0.3	$ 0.6	$ 0.9
Interest cost	1.1	0.9	3.3	2.9
Expected return on plan assets	(1.6)	(1.1)	(4.6)	(3.1)
Amortization of prior service cost	0.6	0.3	0.8	0.7
Net periodic benefit cost (income)	0.3	0.4	0.1	1.4
Nonpension Postretirement Costs
Defined Benefit Plan Disclosure [Line Items]
Service cost	0.1	0.1	0.2	0.3
Interest cost	0.3	0.2	0.8	0.8
Amortization of prior service cost	(0.4)	(0.4)	(1.1)	(0.6)
Net periodic benefit cost (income)	$ 0	$ (0.1)	$ (0.1)	$ 0.5

XML

Commitments, Contingencies and Guarantees - Additional Information (Details) In Millions, unless otherwise specified	9 Months Ended	12 Months Ended		69 Months Ended		0 Months Ended
	Sep. 30, 2014 USD ($) T	Dec. 31, 2010 USD ($)	Dec. 31, 2009 USD ($)	Sep. 30, 2014 USD ($)	Dec. 31, 2010 BRL	Nov. 08, 2011 Oral Care Technology USD ($)	Sep. 30, 2014 Oral Care Technology USD ($)	Sep. 30, 2014 Financial Guarantee USD ($)	Sep. 30, 2014 Collateralized Debt Obligations USD ($)	Nov. 08, 2011 Collateralized Debt Obligations Oral Care Technology USD ($)
Long Term Purchase Commitment [Line Items]
Annual purchase commitment, in tons	240,000
Commitments	$ 231.3
Outstanding letters of credit	4.7			4.7
Guarantees								19.0	3.5	5.5
Cash consideration						4.3
Potential license payment						7.0
Advance royalty payments							4.3
Imposition of fine		2.0			5.0
Remediation and related costs		4.8	3.0
Accrued expenses for remediation, fines and related costs	3.4			3.4
Increase (decrease) in accrued expenses for remediation, fines and related costs				4.4
Cost of landfill removal, minimum	30
Cost of landfill removal, maximum	50
Liabilities for uncertain income tax positions	$ 4.4			$ 4.4

XML

Components of Changes in Accumulated Other Comprehensive Income (Parenthetical) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014		Sep. 30, 2013
Statement Of Stockholders Equity [Abstract]
Amounts of gain reclassified to consolidated statement of income	$ 0.2	$ 0.1	$ 0.6	[1],[2]	$ (0.2)	[1],[2]

[1] Amounts classified to cost of sales and selling, general and administrative expenses.

[2] The Company reclassified a gain of $0.2 and $0.1 out of AOCI to the consolidated statement of income during the three months ended September 30, 2014 and 2013, respectively.

XML

Accounts Payable and Accrued Expenses (Tables)

9 Months Ended

Sep. 30, 2014

Payables And Accruals [Abstract]

Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses consist of the following:

	September 30,		December 31,
	2014		2013
Trade accounts payable	$	278.2	$	256.7
Accrued marketing and promotion costs		125.0		123.7
Accrued wages and related benefit costs		45.5		67.0
Other accrued current liabilities		53.6		47.7
Total	$	502.3	$	495.1

XML

Fair Value of Derivative Instruments and Effect of Such Derivative Instruments on Consolidated Statements of Income and on Other Comprehensive Income (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013
Designated as Hedging Instrument
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Asset Derivatives, Fair Value	$ 1.7		$ 1.7		$ 0.8
Liability Derivatives, Fair Value	1.1		1.1		0
Amount of Gains (Loss) Recognized in OCI	0.9	(0.2)	0	0
Designated as Hedging Instrument | Diesel fuel contracts
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Amount of Gains (Loss) Recognized in OCI	(0.8)	0.2	(1.0)	0
Designated as Hedging Instrument | Diesel fuel contracts | Other Current Assets
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Asset Derivatives, Fair Value	0		0		0.3
Designated as Hedging Instrument | Diesel fuel contracts | Accounts Payable and Accrued Expenses
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Liability Derivatives, Fair Value	1.1		1.1		0
Liability Derivatives, Notional Amount, Volume			5.7
Designated as Hedging Instrument | Foreign Exchange Contract
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Amount of Gains (Loss) Recognized in OCI	1.7	(0.4)	1.0	0
Designated as Hedging Instrument | Foreign Exchange Contract | Other Current Assets
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Asset Derivatives, Notional Amount	68.6		68.6
Asset Derivatives, Fair Value	1.7		1.7		0.5
Not Designated as Hedging Instrument
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Asset Derivatives, Fair Value	0.3		0.3		2.4
Liability Derivatives, Fair Value	0.1		0.1		0
Amount of Gain (Loss) Recognized in Income	0.1	(0.8)	1.4	2.5
Not Designated as Hedging Instrument | Foreign Exchange Contract | Selling, General and Administrative Expenses
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Recognized in Income	0	(0.1)	0	(0.1)
Not Designated as Hedging Instrument | Foreign Exchange Contract | Accounts Payable and Accrued Expenses
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Liability Derivatives, Notional Amount	1.6		1.6
Liability Derivatives, Fair Value	0.1		0.1		0
Not Designated as Hedging Instrument | Equity derivatives | Selling, General and Administrative Expenses
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Recognized in Income	0.1	(0.7)	1.4	2.6
Not Designated as Hedging Instrument | Equity derivatives | Other Current Assets
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Asset Derivatives, Notional Amount	26.6		26.6
Asset Derivatives, Fair Value	$ 0.3		$ 0.3		$ 2.4

XML

Accumulated Other Comprehensive Income

9 Months Ended

Sep. 30, 2014

Equity [Abstract]

Accumulated Other Comprehensive Income

13. Accumulated Other Comprehensive Income

The components of changes in accumulated other comprehensive income (“AOCI”) for the nine months ended September 30, 2014 and September 30, 2013 are as follows:

										Accumulated
	Foreign			Defined						Other
	Currency			Benefit			Derivative			Comprehensive
	Adjustments			Plans			Agreements			Income (Loss)
Balance December 31, 2012	$	22.8		$	(20.5	)	$	0.2		$	2.5
Other comprehensive income before reclassifications		(7.0	)		0.0			0.0			(7.0	)
Amounts reclassified to consolidated statement of    income (a) (b)		0.0			0.2			0.0			0.2
Other comprehensive income (loss)		(7.0	)		0.2			0.0			(6.8	)
Balance September 30, 2013	$	15.8		$	(20.3	)	$	0.2		$	(4.3	)
Balance December 31, 2013	$	12.7		$	(13.0	)	$	0.5		$	0.2
Other comprehensive income before reclassifications		(14.8	)		1.0			0.4			(13.4	)
Amounts reclassified to consolidated statement of    income (a) (b)		0.0			0.0			(0.6	)		(0.6	)
Tax benefit (expense)		0.0			(0.3	)		0.2			(0.1	)
Other comprehensive income (loss)		(14.8	)		0.7			0.0			(14.1	)
Balance September 30, 2014	$	(2.1	)	$	(12.3	)	$	0.5		$	(13.9	)

^(a) Amounts classified to cost of sales and selling, general and administrative expenses.

^(b) The Company reclassified a gain of $0.2 and $0.1 out of AOCI to the consolidated statement of income during the three months ended September 30, 2014 and 2013, respectively.

XML

Inventories (Tables)

9 Months Ended

Sep. 30, 2014

Inventory Disclosure [Abstract]

Components of Inventories

Inventories consist of the following:

	September 30,		December 31,
	2014		2013
Raw materials and supplies	$	68.4	$	70.2
Work in process		27.0		30.4
Finished goods		166.2		149.9
Total	$	261.6	$	250.5

XML

Carrying Amounts and Estimated Fair Values of Other Financial Instruments (Details) (Fair Value, Inputs, Level 2, USD $) In Millions, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Carrying Amount
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash equivalents	$ 240.3	$ 318.5
Short-term borrowings	404.1	153.8
Carrying Amount | 2.875% Senior notes due October 1, 2022
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	399.7	399.7
Carrying Amount | 3.35% Senior Notes Due December 15, 2015
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	249.9	249.8
Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash equivalents	240.3	318.5
Short-term borrowings	404.1	153.8
Fair Value | 2.875% Senior notes due October 1, 2022
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	386.7	369.8
Fair Value | 3.35% Senior Notes Due December 15, 2015
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	$ 258.0	$ 258.2

XML

Components of Inventories (Details) (USD $) In Millions, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Inventory, Finished Goods and Work in Process, Net of Reserves [Abstract]
Raw materials and supplies	$ 68.4	$ 70.2
Work in process	27.0	30.4
Finished goods	166.2	149.9
Total	$ 261.6	$ 250.5

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $) In Millions, except Share data, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Statement Of Financial Position [Abstract]
Accounts receivable, allowances	$ 1.5	$ 0.8
Preferred Stock, par value	$ 1.00	$ 1.00
Preferred Stock, Authorized	2,500,000	2,500,000
Preferred Stock, issued	0	0
Common Stock, par value	$ 1.00	$ 1.00
Common Stock, Authorized	300,000,000	300,000,000
Common Stock, shares issued	146,427,550	146,427,550
Common stock in treasury, shares	12,806,896	7,462,913

XML

New Accounting Pronouncements Adopted

9 Months Ended

Sep. 30, 2014

Accounting Changes And Error Corrections [Abstract]

New Accounting Pronouncements Adopted

2. New Accounting Pronouncements Adopted

In May 2014, the Financial Accounting Standards Board issued new guidance that clarifies the principles for recognizing revenue.  The new guidance provides that an entity should recognize revenue for the transfer of goods or services equal to the amount that it expects to receive for those goods or services.  The new guidance is effective for annual and interim periods beginning after December 15, 2016, and allows companies to apply the requirements retrospectively, either to all prior periods presented or through a cumulative adjustment in the year of adoption.  Early adoption is not allowed. The Company is currently evaluating the impact, if any, that the adoption of the new guidance will have on its consolidated financial position, results of operations or cash flows.

There have been no other accounting pronouncements issued but not yet adopted by the Company which are expected to have a material impact on the Company’s consolidated financial position, results of operations or cash flows.

XML

Carrying Amount of Goodwill (Details) (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2014
Goodwill [Line Items]
Beginning balance	$ 1,222.2
Lil' Drug Store Brands acquired goodwill	102.8
Ending balance	1,325.0
Consumer Domestic
Goodwill [Line Items]
Beginning balance	1,154.8
Lil' Drug Store Brands acquired goodwill	102.8
Ending balance	1,257.6
Consumer International
Goodwill [Line Items]
Beginning balance	47.2
Lil' Drug Store Brands acquired goodwill	0
Ending balance	47.2
Specialty Products
Goodwill [Line Items]
Beginning balance	20.2
Lil' Drug Store Brands acquired goodwill	0
Ending balance	$ 20.2

XML

Segments - Additional Information (Details)	9 Months Ended
	Sep. 30, 2014 Segment	Sep. 30, 2014 Equity Method Investee Armand Products Company	Sep. 30, 2013 Equity Method Investee Armand Products Company	Sep. 30, 2014 Equity Method Investee Armakleen Company	Sep. 30, 2013 Equity Method Investee Armakleen Company	Sep. 30, 2014 Equity Method Investee Natronx LLC	Sep. 30, 2013 Equity Method Investee Natronx LLC
Segment Reporting Information [Line Items]
Number of reportable segments	3
Percentage of ownership interest		50.00%	50.00%	50.00%	50.00%	33.33%	33.33%

XML

Property, Plant and Equipment, Net ("PP&E") (Tables)

9 Months Ended

Sep. 30, 2014

Property Plant And Equipment [Abstract]

Components of Property, Plant and Equipment

PP&E consist of the following:

	September 30,		December 31,
	2014		2013
Land	$	25.6	$	25.7
Buildings and improvements		281.1		280.4
Machinery and equipment		596.1		577.5
Software		84.1		83.0
Office equipment and other assets		61.4		57.7
Construction in progress		59.2		42.9
Gross Property, Plant and Equipment		1,107.5		1,067.2
Less accumulated depreciation and amortization		511.7		473.1
Net Property, Plant and Equipment	$	595.8	$	594.1

	Three Months Ended				Nine Months Ended
	September 30,		September 30,		September 30,		September 30,
	2014		2013		2014		2013
Depreciation and amortization on PP&E	$	13.9	$	14.1	$	43.3	$	44.9
Interest charges capitalized (in construction in    progress)	$	0.2	$	0.1	$	0.5	$	0.3

XML

Related Party Transactions (Tables)

9 Months Ended

Sep. 30, 2014

Related Party Transactions [Abstract]

Schedule of Related Party Transactions

The following summarizes the balances and transactions between the Company and each of (i) Armand Products Company (“Armand”) and The ArmaKleen Company (“ArmaKleen”), in which the Company holds a 50% ownership interest, and (ii) Natronx, in which the Company holds a one-third ownership interest:

	Armand				ArmaKleen				Natronx
	Nine Months Ended				Nine Months Ended				Nine Months Ended
	September 30,		September 30,		September 30,		September 30,		September 30,		September 30,
	2014		2013		2014		2013		2014		2013
Purchases by Company	$	20.3	$	17.1	$	0.0	$	0.0	$	0.0	$	0.0
Sales by Company	$	0.0	$	0.0	$	0.9	$	1.0	$	1.5	$	1.3
Outstanding Accounts    Receivable	$	0.2	$	0.5	$	0.6	$	0.4	$	0.1	$	0.1
Outstanding Accounts Payable	$	2.8	$	2.0	$	0.0	$	0.0	$	0.0	$	0.0
Administration & Management    Oversight Services (1)	$	1.7	$	1.4	$	1.5	$	1.6	$	0.6	$	0.9

⁽¹⁾ Billed by Company and recorded as a reduction of selling, general and administrative expenses.

XML

Short-Term Borrowings and Long-Term Debt

9 Months Ended

Sep. 30, 2014

Debt Disclosure [Abstract]

Short-Term Borrowings and Long-Term Debt

12. Short-Term Borrowings and Long-Term Debt

Short-term borrowings and long-term debt consist of the following:

	September 30,			December 31,
	2014			2013
Short-term borrowings
Commercial paper issuances	$	400.0		$	150.0
Various debt due to international banks		4.1			3.8
Total short-term borrowings	$	404.1		$	153.8
Long-term debt
2.875% Senior notes due October 1, 2022	$	400.0		$	400.0
Less: Discount		(0.3	)		(0.3	)
3.35% Senior notes due December 15, 2015		250.0			250.0
Less: Discount		(0.1	)		(0.2	)
Net long-term debt	$	649.6		$	649.5